<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7825331</article-id><article-id pub-id-type="pmid">33419035</article-id><article-id pub-id-type="doi">10.3390/molecules26020251</article-id><article-id pub-id-type="publisher-id">molecules-26-00251</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Medicinal Properties and Bioactive Compounds from Wild Mushrooms Native to North America</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0879-0468</contrib-id><name><surname>Zeb</surname><given-names>Mehreen</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Chow H.</given-names></name><xref rid="c1-molecules-26-00251" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Leon</surname><given-names>Francisco</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Barros</surname><given-names>Lillian</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-26-00251">Chemistry and Biochemistry Program, University of Northern British Columbia, Prince George, BC V2N 4Z9, Canada; <email>zeb@unbc.ca</email></aff><author-notes><corresp id="c1-molecules-26-00251"><label>*</label>Correspondence: <email>chow.lee@unbc.ca</email>; Tel.: +1-250-960-5413</corresp></author-notes><pub-date pub-type="epub"><day>06</day><month>1</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2021</year></pub-date><volume>26</volume><issue>2</issue><elocation-id>251</elocation-id><history><date date-type="received"><day>18</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>03</day><month>1</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 by the authors.</copyright-statement><copyright-year>2021</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Mushrooms, the fruiting bodies of fungi, are known for a long time in different cultures around the world to possess medicinal properties and are used to treat various human diseases. Mushrooms that are parts of traditional medicine in Asia had been extensively studied and this has led to identification of their bioactive ingredients. North America, while home to one of the world&#x02019;s largest and diverse ecological systems, has not subjected its natural resources especially its diverse array of mushroom species for bioprospecting purposes: Are mushrooms native to North America a good source for drug discovery? In this review, we compile all the published studies up to September 2020 on the bioprospecting of North American mushrooms. Out of the 79 species that have been investigated for medicinal properties, 48 species (60%) have bioactivities that have not been previously reported. For a mere 16 selected species, 17 new bioactive compounds (10 small molecules, six polysaccharides and one protein) have already been isolated. The results from our literature search suggest that mushrooms native to North America are indeed a good source for drug discovery.</p></abstract><kwd-group><kwd>wild mushrooms</kwd><kwd>fungi</kwd><kwd>medicinal mushrooms</kwd><kwd>bioactive compounds</kwd><kwd>North America</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-26-00251"><title>1. Introduction</title><p>Natural products have been used as medicines for centuries, however, only in the last century have researchers begun to diligently characterize their biological and chemical properties. Mushrooms are natural reservoirs of potent pharmaceuticals and are now the new interface for drug discovery. Mushrooms belong to ascomycetes and basidiomycetes phyla of the kingdom Fungi, and have been defined as &#x0201c;<italic>epigeous and hypogeous fruiting bodies of macroscopic fungi</italic>&#x0201d; [<xref rid="B1-molecules-26-00251" ref-type="bibr">1</xref>]. According to the recent estimates, fungi constitute 2.2&#x02013;3.8 million species worldwide [<xref rid="B2-molecules-26-00251" ref-type="bibr">2</xref>]. These fungal estimates include all the different types of fungi including mushrooms, the fruiting bodies of fungi. Another study provides estimates on the total number of mushrooms to be 140,000&#x02013;160,000 where only 10% have been explored [<xref rid="B3-molecules-26-00251" ref-type="bibr">3</xref>,<xref rid="B4-molecules-26-00251" ref-type="bibr">4</xref>].</p><p>Mushrooms have a long history of medicinal use in various cultures across the globe. It has earned medicinal status long ago in China and other parts of Asia, including Japan and Korea. The scope of medicinal mushrooms has expanded to other countries such as USA and the eastern European countries such as Russia [<xref rid="B5-molecules-26-00251" ref-type="bibr">5</xref>,<xref rid="B6-molecules-26-00251" ref-type="bibr">6</xref>,<xref rid="B7-molecules-26-00251" ref-type="bibr">7</xref>,<xref rid="B8-molecules-26-00251" ref-type="bibr">8</xref>,<xref rid="B9-molecules-26-00251" ref-type="bibr">9</xref>]. Initially, mushrooms became popular as a folklore remedy. For example, in the sixteenth century in Russia and Europe, <italic>Inonotus obliquus</italic> became famous as a folklore medicine for the treatment of cancer [<xref rid="B10-molecules-26-00251" ref-type="bibr">10</xref>]. Later on, scientists became interested in finding the evidence behind the diverse bioactive potential that is contained in mushrooms. This has led to the exploration of untapped mushroom resources for their potential medicinal benefit and the bioactive compounds that impart these properties. There are many excellent recent reviews written on the topic of medicinal mushrooms and the bioactive compounds that derived from them [<xref rid="B11-molecules-26-00251" ref-type="bibr">11</xref>,<xref rid="B12-molecules-26-00251" ref-type="bibr">12</xref>,<xref rid="B13-molecules-26-00251" ref-type="bibr">13</xref>,<xref rid="B14-molecules-26-00251" ref-type="bibr">14</xref>]. Unlike in Asia and parts of Eastern Europe, there are relatively less studies on the exploration of mushrooms native to North America for medicinal properties.</p><p>The purpose of this comprehensive review is to provide an up-to-date information on the bioprospecting efforts on mushrooms native to North America. With literature searches and the information gained, we aim to critically answer the following questions: (i) Do similar species found in North America and elsewhere exhibit similar bioactivities and produce similar group of bioactive compounds?, (ii) Do similar species found in North America and elsewhere exhibit distinct bioactivity and produce distinct compounds?, (iii) Do new species found in North America produce new compound(s), and (iv) Based on the answers to (i) to (iii) above, is it worth exploring mushrooms native to North America for medicinal properties and for new medicinal compounds?</p><p>To review and answer the above questions, we performed literature search on the following database; Google Scholar, Science Direct, and PubMed. Some of the key search terms used included &#x0201c;medicinal mushrooms from North America&#x0201d;, &#x0201c;North American mushrooms&#x0201d;, &#x0201c;bioactive compounds from North American mushrooms&#x0201d;, &#x0201c;small molecules from mushrooms&#x0201d;, &#x0201c;large molecular weight compounds from medicinal mushrooms&#x0201d;, &#x0201c;medicinal mushrooms of British Columbia&#x0201d;, &#x0201c;medicinal mushrooms of Canada&#x0201d;, &#x0201c;medicinal mushrooms and United States&#x0201d;, and &#x0201c;medicinal mushrooms and Greenland&#x0201d;. The search was limited to the period from 2005&#x02013;2020 and articles that have irrelevant topic such as morphology, taxonomy and ecological aspects of mushrooms were excluded. Research articles that involved biological activity and chemical characterization were included.</p></sec><sec id="sec2-molecules-26-00251"><title>2. Mushrooms Native to North America</title><p>North America covering the northern subcontinent of the Americas that includes Canada, the United States, and Greenland, has one of the world&#x02019;s largest and diverse ecological system. It is also home to diverse mushrooms that are relatively unexplored for their therapeutic benefit. Although new species continue to be discovered in North America, about 22&#x02013;55% of the mushroom species remain unexplored [<xref rid="B3-molecules-26-00251" ref-type="bibr">3</xref>]. Like elsewhere, mushrooms were recognized as an important source for medicine by people who lived in North America centuries ago. For example, the indigenous people of North America had used <italic>Calvatia</italic> mushrooms (more commonly known as puffballs) to heal wounds [<xref rid="B15-molecules-26-00251" ref-type="bibr">15</xref>]. The therapeutic value of <italic>Fomitopsis officinalis</italic> was also discovered by First Nations peoples of North America, including those in British Columbia (BC) where <italic>F. officinalis</italic> sporophores were carved as shaman grave guardians [<xref rid="B16-molecules-26-00251" ref-type="bibr">16</xref>].</p><p>In the recent years, there has been increasing reports on mushrooms native to North America possessing medicinal properties. Whether it be <italic>Hericium</italic> sp. which is found growing on hardwood and coniferous trees that contains a number of small molecules with antibacterial properties [<xref rid="B17-molecules-26-00251" ref-type="bibr">17</xref>] or <italic>Echinodontium tinctorium</italic> which is native to BC commonly found growing as a woody conk on true firs with anti-inflammatory compound in its fruiting bodies [<xref rid="B18-molecules-26-00251" ref-type="bibr">18</xref>]. Others include <italic>Cortinarius armillatus</italic> which grows in moist coniferous forests and contains orellanine, a potential toxin against renal carcinoma [<xref rid="B19-molecules-26-00251" ref-type="bibr">19</xref>,<xref rid="B20-molecules-26-00251" ref-type="bibr">20</xref>]. In <xref rid="molecules-26-00251-t001" ref-type="table">Table 1</xref>, we summarize all the mushrooms found in North America that have been reported to possess medicinal properties, their origin of collection, types of bioactive components, and their active doses.</p></sec><sec id="sec3-molecules-26-00251"><title>3. Medicinal Properties of Mushrooms Native to North America</title><p>Mushrooms are known to possess medicinal properties that provide benefits against a large number of diseases. Some of the important medicinal benefits reported include antimicrobial, antioxidant, anticancer, immune system enhancer, antiviral, anti-hyperlipidemia, radical scavenger, anti-parasitic and anti-inflammatory [<xref rid="B42-molecules-26-00251" ref-type="bibr">42</xref>]. Amongst these, the most common medicinal properties reported from mushrooms native to North America are anti-cancer, immuno-stimulatory, anti-inflammatory, antimicrobial and antioxidant as shown in <xref rid="molecules-26-00251-t001" ref-type="table">Table 1</xref> [<xref rid="B17-molecules-26-00251" ref-type="bibr">17</xref>,<xref rid="B18-molecules-26-00251" ref-type="bibr">18</xref>,<xref rid="B19-molecules-26-00251" ref-type="bibr">19</xref>,<xref rid="B20-molecules-26-00251" ref-type="bibr">20</xref>,<xref rid="B21-molecules-26-00251" ref-type="bibr">21</xref>,<xref rid="B22-molecules-26-00251" ref-type="bibr">22</xref>,<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>,<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>,<xref rid="B25-molecules-26-00251" ref-type="bibr">25</xref>,<xref rid="B26-molecules-26-00251" ref-type="bibr">26</xref>,<xref rid="B27-molecules-26-00251" ref-type="bibr">27</xref>,<xref rid="B28-molecules-26-00251" ref-type="bibr">28</xref>,<xref rid="B29-molecules-26-00251" ref-type="bibr">29</xref>,<xref rid="B30-molecules-26-00251" ref-type="bibr">30</xref>,<xref rid="B31-molecules-26-00251" ref-type="bibr">31</xref>,<xref rid="B32-molecules-26-00251" ref-type="bibr">32</xref>,<xref rid="B33-molecules-26-00251" ref-type="bibr">33</xref>,<xref rid="B34-molecules-26-00251" ref-type="bibr">34</xref>,<xref rid="B35-molecules-26-00251" ref-type="bibr">35</xref>,<xref rid="B36-molecules-26-00251" ref-type="bibr">36</xref>,<xref rid="B37-molecules-26-00251" ref-type="bibr">37</xref>,<xref rid="B38-molecules-26-00251" ref-type="bibr">38</xref>,<xref rid="B39-molecules-26-00251" ref-type="bibr">39</xref>,<xref rid="B41-molecules-26-00251" ref-type="bibr">41</xref>].</p><sec id="sec3dot1-molecules-26-00251"><title>3.1. Anti-Bacterial and Anti-Viral Activities</title><p>Antimicrobial resistance is a major healthcare problem worldwide. A recent landmark report indicated that bacterial infections resistant to treatment are likely to grow from 26% in 2018 to 40% By 2050, and such increases are expected to cost thousands of lives, billions of dollars in hospital expenses and gross domestic product and have a negative social impact on people worldwide [<xref rid="B43-molecules-26-00251" ref-type="bibr">43</xref>]. Therefore, it is recommended that efforts to discover new antimicrobial drugs to combat specific antibiotic-resistant pathogens should be strengthened and should include innovative strategies [<xref rid="B43-molecules-26-00251" ref-type="bibr">43</xref>,<xref rid="B44-molecules-26-00251" ref-type="bibr">44</xref>,<xref rid="B45-molecules-26-00251" ref-type="bibr">45</xref>]. Many studies around the world had focused on isolating antibacterial compounds and extracts from basidiomycete mushrooms [<xref rid="B46-molecules-26-00251" ref-type="bibr">46</xref>]. For instance, the small molecules enokipodins A&#x02013;D, isolated from <italic>Flammulina velutipes</italic> had activity against <italic>Bacillus subtilis</italic> and <italic>Staphylococcus aureus</italic> [<xref rid="B47-molecules-26-00251" ref-type="bibr">47</xref>], while others including emodin, physcion, and erythroglaucin, austrocortilutein, torosachrysone, and 6-methylxanthopurpurin-3-<italic>O</italic>-methyl ether isolated from <italic>Cortinarius</italic> species were effective against <italic>S. aureus</italic> [<xref rid="B48-molecules-26-00251" ref-type="bibr">48</xref>]. Small molecules from <italic>Lentinus edodes</italic> (Shiitake mushroom) have also shown antibacterial effects against <italic>S. aureus, Streptococcus faecalis</italic> and <italic>Bacillus cereus</italic> [<xref rid="B49-molecules-26-00251" ref-type="bibr">49</xref>].</p><p>Not surprisingly, researchers have also focused on mushrooms native to North America, as avenues to discover novel antimicrobial metabolites. Grifolin, neogrifolin and confluentin isolated from <italic>Albatrellus flettii</italic> collected in California were found to have strong activity against gram positive bacteria <italic>B. cereus</italic> and <italic>Enterococcus faecalis</italic> [<xref rid="B21-molecules-26-00251" ref-type="bibr">21</xref>]. Another lanostane-type tripterpene isolated from <italic>Jahnoporus hirtus</italic> also inhibited the growth of <italic>B. cereus</italic> and <italic>E. faecalis</italic> [<xref rid="B21-molecules-26-00251" ref-type="bibr">21</xref>]. Other anti-bacterial small molecules isolated include lanostane triterpenoids and ergostane steroid from <italic>Fomitopsis pinicola</italic> collected in Oregon [<xref rid="B30-molecules-26-00251" ref-type="bibr">30</xref>], new subclass of bisnaphthalenes from <italic>Urnula craterium</italic> [<xref rid="B41-molecules-26-00251" ref-type="bibr">41</xref>] collected in La Crosse (WI, USA) and 2-aminoquinoline from <italic>Leucopaxillus albissimus</italic> [<xref rid="B36-molecules-26-00251" ref-type="bibr">36</xref>]. 2-aminoquinoline showed modest antibacterial activity against multidrug resistant clinical isolates with an MIC of 8&#x02013;64 &#x003bc;g/mL and weak antibacterial activity against <italic>A. baumannii</italic>, using tetracycline as a reference antibacterial agent [<xref rid="B36-molecules-26-00251" ref-type="bibr">36</xref>]. The antibacterial activity of 2-aminoquinoline was not very convincing due to its high MIC, therefore, it was not suggested for further drug screening as an antibacterial agent in its current form. The antibacterial activity of small molecules from <italic>F. pinicola</italic> was compared with tetracycline [<xref rid="B30-molecules-26-00251" ref-type="bibr">30</xref>]. Vancomycin and tetracycline were used as positive controls to compare the antimicrobial activity of urnucratin A-C isolated from <italic>Urnula craterium</italic> [<xref rid="B41-molecules-26-00251" ref-type="bibr">41</xref>]. Amongst these compounds, urnucratin A (26) was the most promising with MIC values of 2, 1, and 0.5 &#x003bc;g/mL against <italic>S. aureus</italic>, <italic>E. faecium</italic> and <italic>S. pyogenes</italic> respectively [<xref rid="B41-molecules-26-00251" ref-type="bibr">41</xref>]. It had an IC50 value greater than 100 &#x003bc;M against J774A.1 murine monocyte cells, indicating that it lacks non-specific toxicity [<xref rid="B41-molecules-26-00251" ref-type="bibr">41</xref>]. Supernatants from culture of <italic>Lenzites betulina</italic> and <italic>Haploporus odorus</italic> [<xref rid="B33-molecules-26-00251" ref-type="bibr">33</xref>] as well as extracts from <italic>Pleurotus ostreatus</italic> and <italic>P. levis</italic> [<xref rid="B39-molecules-26-00251" ref-type="bibr">39</xref>] also have antimicrobial activity. However, the responsible antimicrobial compounds have not been isolated from these mushrooms. In another study using extracts from 75 mushrooms collected in Oxford (OH, USA), it was found that a total of 25 samples had antibacterial activity against at least one of the bacterial strains assessed [<xref rid="B26-molecules-26-00251" ref-type="bibr">26</xref>]. From this study, extracts from <italic>Ganoderma lucidum</italic> and <italic>Laetiporus sulphureus</italic> were found to have the strongest antibacterial activity [<xref rid="B26-molecules-26-00251" ref-type="bibr">26</xref>]. MIC was determined for these mushroom extracts using kanamycin as a reference antibacterial agent which has an MIC of 0.01 mg/mL against <italic>S. epidermidis</italic> [<xref rid="B26-molecules-26-00251" ref-type="bibr">26</xref>]. Four small molecules Ramariolides A&#x02013;D (22&#x02013;25) were isolated from methanol extracts of <italic>Ramaria cystidiophora</italic> [<xref rid="B50-molecules-26-00251" ref-type="bibr">50</xref>]. The major metabolite ramariolide A (21) was found to be active against <italic>Mycobacterium smegmatis</italic> and <italic>Mycobacterium tuberculosis</italic> with MIC of 8 &#x003bc;g/mL and 64&#x02212;128 &#x003bc;g/mL respectively. This compound appears to be promising because isoniazid, a first-line antituberculosis bactericidal antibiotic also has an MIC of 8 &#x003bc;g/mL against <italic>M. smegmatis</italic> [<xref rid="B50-molecules-26-00251" ref-type="bibr">50</xref>]. The authors did not report any antibacterial from ramariolides B&#x02013;D (22&#x02013;24), and therefore it is currently unknown whether these compounds have any biological activity.</p><p>Extracts of polypore mushrooms native to North America have been shown to have antiviral activities against viruses that attack honeybees [<xref rid="B51-molecules-26-00251" ref-type="bibr">51</xref>]. Mycelium extracts from <italic>Fomes fomentarius</italic> collected in Ithaca (NY, USA) and <italic>Ganoderma resinaceum</italic> culture from Ontario (Canada) were found to reduce the levels of honeybee deformed wing virus and Lake Sinai virus in vivo in both laboratory and field studies [<xref rid="B51-molecules-26-00251" ref-type="bibr">51</xref>].</p></sec><sec id="sec3dot2-molecules-26-00251"><title>3.2. Anti-Proliferative Activity</title><sec id="sec3dot2dot1-molecules-26-00251"><title>3.2.1. Anti-Proliferative Activity In-Vitro</title><p>Mushrooms native to North America have been explored for anti-proliferative activity against cancer cell lines. For instance, out of 29 species of mushrooms examined from north-central BC [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>] and Haida Gwaii, BC [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>], 27 species exhibited anti-proliferative activity. Sixteen out of the 27 species (59%) had their anti-proliferative activity reported for the first time [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>,<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]. These species include <italic>Amanita augusta, Cantharellus cibarius, Chroogomphus tomentosus, Guepinia helvelloides, Gyromitra esculenta, Hydnellum</italic> sp., <italic>Inocybe</italic> sp., <italic>Laetiporus conifericola, Leucocybe connata, Phellodon atratus, Pleurotus ostreatus, Ramaria cystidiophora, Russula paludosa, Trichaptum abietinum, Tricholomopsis rutilans</italic>, and <italic>Tyromyces chioneus</italic>. It would be of interest to further investigate what the anti-proliferative compounds from these mushrooms are. Another study was conducted on 38 species of mushrooms collected from the greater Seattle area (WA, USA). Out of 38 species, aqueous extracts from three species were identified as anti-proliferative in human estrogen receptor negative (MDA-MB-231, BT-20) and estrogen receptor positive (MCF-7) breast cancer cells. These included <italic>Coprinus comatus</italic>, <italic>Coprinellus</italic> sp., and <italic>Flammulina velutipes</italic> [<xref rid="B27-molecules-26-00251" ref-type="bibr">27</xref>]. The anti-proliferative effects of these 3 species were compared with 5-fluorouracil, a known anticancer drug [<xref rid="B27-molecules-26-00251" ref-type="bibr">27</xref>]. Elsewhere, the ethanol and water extracts of <italic>Pleurotus tuber-regium</italic> from Washington State displayed anti-proliferative effects in HCT-116 colon and HeLa cervical cancer cell lines [<xref rid="B52-molecules-26-00251" ref-type="bibr">52</xref>]. Although in most parts the identity of anti-proliferative compounds from the mushroom species described above remains unknown, there were detailed structural elucidation and mechanistic studies of both bioactive small molecules and polysaccharides isolated from selected species. For example, a growth-inhibitory polysaccharide GIPinv that caused growth inhibition in several cancer cell lines and induced apoptosis in HeLa cancer cells was isolated from <italic>Paxillus involutus</italic> [<xref rid="B37-molecules-26-00251" ref-type="bibr">37</xref>]. It has an IC50 of 0.05 mg/mL and 0.04 mg/mL against HeLa cells and MCF-7 cells respectively. In the future, GIPinv should be evaluated for its anticancer activity in animal models. Small molecules grifolin, neogrifolin and confluentin were found to be the major growth-inhibitory compounds in the ethanol extracts of <italic>Albatrellus flettii</italic> [<xref rid="B22-molecules-26-00251" ref-type="bibr">22</xref>]. It was also discovered that confluentin can inhibit the RNA-binding function of the oncogenic protein insulin-like growth factor 2 mRNA-binding protein 1 (IMP1) [<xref rid="B22-molecules-26-00251" ref-type="bibr">22</xref>]. This is potentially a novel inhibitory pathway leading to the suppression of KRAS expression in human colon cancer cells. To determine the significance of this finding, it will be important to evaluate the inhibitory function of confluentin using in vivo models. Elsewhere, an exopolysaccharide isolated from <italic>P. tuber-regium</italic> inhibited the growth of chronic myelogenous leukemia K562 cells [<xref rid="B40-molecules-26-00251" ref-type="bibr">40</xref>]. Another example is orenalline, a small molecule isolated from <italic>Cortinarius armillatus</italic> that inhibited renal carcinoma in a dose-dependent manner [<xref rid="B20-molecules-26-00251" ref-type="bibr">20</xref>].</p></sec><sec id="sec3dot2dot2-molecules-26-00251"><title>3.2.2. Anti-Proliferative/Anti-Cancer Activity in Animal Models</title><p>To the best of our knowledge, to date there has been no animal studies for anticancer activity of any compounds isolated from North American mushroom. There are numerous animal studies reporting the anti-cancer activity of extracts, small molecules and large molecules isolated from mushrooms collected in different parts of the world. Several excellent reviews have already dealt with this topic [<xref rid="B11-molecules-26-00251" ref-type="bibr">11</xref>,<xref rid="B12-molecules-26-00251" ref-type="bibr">12</xref>,<xref rid="B13-molecules-26-00251" ref-type="bibr">13</xref>,<xref rid="B14-molecules-26-00251" ref-type="bibr">14</xref>]. Here, we only highlight some of the key findings from popular medicinal mushrooms. A mushroom mixture named as Micotherapy U-care consisted of <italic>G. lucidum, Lentinula edodes, Agaricus blazei, Ophiocordyceps sinensis,</italic> and <italic>Grifola frondosa</italic> was orally administered in mice implanted with triple-negative breast cancer. The results showed reduced pulmonary metastases density as well as decreased expression of interleukin-6, NOS, and COX-2 [<xref rid="B53-molecules-26-00251" ref-type="bibr">53</xref>]. In another study, the anticancer effect of &#x003b2;-glucans along with radiation therapy was evaluated against lung cancer. The &#x003b2;-glucan isolated from <italic>G. lucidum</italic> caused inhibition of primary lung cancer metastasis in C57BL/6 mice [<xref rid="B54-molecules-26-00251" ref-type="bibr">54</xref>]. In another study, the antitumor effects of a &#x003b2;-glucan isolated from <italic>G. frondosa</italic> combined with cisplatin were evaluated in a BALB/cA mouse model. The &#x003b2;-glucan was able to enhance the antitumor and antimetastatic effects of cisplatin as well as reduced the side effects; myelosuppression and nephrotoxicity, associated with cisplatin treatment [<xref rid="B55-molecules-26-00251" ref-type="bibr">55</xref>]. The ethanol extracts from <italic>F. pinicola</italic> has been shown to significantly inhibit xenograft sarcoma-derived tumor growth in mice and prolong their survival time when administered as a food supplement [<xref rid="B56-molecules-26-00251" ref-type="bibr">56</xref>].</p><p><italic>Hericium erinaceus</italic> is one of the medicinal mushrooms that has been most extensively studied in animal models [<xref rid="B11-molecules-26-00251" ref-type="bibr">11</xref>]. For example, its ethanol extract was able to inhibit gastric, liver and colon cancer in mouse xenograft tumors [<xref rid="B57-molecules-26-00251" ref-type="bibr">57</xref>] while its water extracts has been shown to possess anti-metastatic activity by inhibiting the migration of colon carcinoma cells to lungs [<xref rid="B58-molecules-26-00251" ref-type="bibr">58</xref>]. Two compounds isolated from <italic>H. erinaceus</italic> were demonstrated to possess anti-cancer activity in pre-clinical mouse models. The cyanthine diterpenoid Erinacine A has shown inhibition of DLD-1 human colorectal adenocarcinoma xenograft tumor growth in nude mice [<xref rid="B59-molecules-26-00251" ref-type="bibr">59</xref>]. A protein isolated from <italic>H. erinaceus</italic> called HEP3 also showed ability to inhibit growth of colon cancer cells in mouse xenograft tumors [<xref rid="B60-molecules-26-00251" ref-type="bibr">60</xref>]. Animal studies have also been conducted with <italic>I. obliquus</italic>, <italic>Trametes versicolor</italic> and <italic>Phellinus linteus</italic>. A proteoglycan isolated from <italic>P. linteus</italic> was able to potentiate immune system as well as inhibit cancer in HT-29-bearing BALB/c-nu/nu mice by inhibiting Reg IV/EGFR/Akt signaling pathway [<xref rid="B61-molecules-26-00251" ref-type="bibr">61</xref>]. As for <italic>I. obliquus</italic>, its extracts were capable of inhibiting tumor growth in human melanoma B16-F10 cells- and sarcoma-180 cells-derived xenografts in mice [<xref rid="B62-molecules-26-00251" ref-type="bibr">62</xref>,<xref rid="B63-molecules-26-00251" ref-type="bibr">63</xref>]. Specific compounds isolated from <italic>I. obliquus</italic> have shown anti-cancer activity in vivo. Two unique lanostane-type, inonotodiol and inonotsuoxides, have demonstrated anti-carcinogenic effects on mouse skin and human leukemia-derived mouse xenograft tumors [<xref rid="B64-molecules-26-00251" ref-type="bibr">64</xref>,<xref rid="B65-molecules-26-00251" ref-type="bibr">65</xref>]. For <italic>T. versicolor</italic>, the &#x003b2;&#x02013;glucan-based polysaccharopeptide fraction PSP exhibited growth-inhibitory effect on a number of cancer cells in mouse xenograft tumors [<xref rid="B11-molecules-26-00251" ref-type="bibr">11</xref>]. In addition, a new glucan isolated from the water extract of <italic>T. versicolor</italic> was able to inhibit the xenograft sarcoma growth in mice [<xref rid="B66-molecules-26-00251" ref-type="bibr">66</xref>].</p></sec><sec id="sec3dot2dot3-molecules-26-00251"><title>3.2.3. Anti-Proliferative/Anti-Cancer Activity in Humans</title><p>To date, there has been no clinical studies evaluating the anti-cancer potential of mushrooms native to North America. However, there are 600 published papers and reports of clinical therapeutic effects of medicinal mushrooms collected from different parts of the world. Here, we highlight some of the key clinical studies. Perhaps, the most clinically-relevant anti-cancer compounds from mushroom are PSP and polysaccharide-K (PSK). These immunotherapeutic anti-cancer compounds had been extensively studied clinically and have been in use in Japan since 1977 and in China since 1987 [<xref rid="B11-molecules-26-00251" ref-type="bibr">11</xref>]. Another mushroom that has been studied extensively on humans is <italic>G. lucidum</italic>, commonly known as Reishi or Ling Zhi in Asia [<xref rid="B42-molecules-26-00251" ref-type="bibr">42</xref>]. One such clinical study was conducted on Ganopoly, a polysaccharide isolated from <italic>G. lucidum</italic>. A randomized controlled double blinded clinical trial on 68 patients with advanced lung cancer was conducted to evaluate the efficacy and safety of Ganopoly. Patients were evaluated after 12 weeks of administration of Ganopoly. Ganopoly was found to enhance the host immune function by increasing the activity of macrophages, T lymphocytes and natural killer cells, suggesting its role as an adjunct [<xref rid="B67-molecules-26-00251" ref-type="bibr">67</xref>]. Another study was conducted on 47 patients with advanced colorectal cancer in which 5.4 g/day doses of Ganopoly was administered to patients for 12 weeks. Ganopoly was found to stimulate the immune response in the cancer patients [<xref rid="B68-molecules-26-00251" ref-type="bibr">68</xref>].</p><p>A phase I/II dose escalation trial has been carried out using polysaccharide extract from <italic>G. frondosa</italic>, also known as Maitake mushroom. The efficacy of the polysaccharide extract was evaluated at multiple doses ranging from 0.1&#x02013;6 mg/kg two times daily for 3 weeks. Thirty postmenopausal breast cancer patients were enrolled and were sub-divided into 5 cohorts with 6 patients in each cohort. The polysaccharide extract stimulated the immune response at a dose of 6mg/kg [<xref rid="B69-molecules-26-00251" ref-type="bibr">69</xref>]. A hospital-based case controlled study was conducted to assess the combined effect of edible mushrooms and green tea on breast cancer. The study showed a reduced risk of breast cancer in both pre- and postmenopausal breast cancer patients due to high intake of <italic>A. bisporus</italic>, <italic>L. edodes</italic> and green tea [<xref rid="B70-molecules-26-00251" ref-type="bibr">70</xref>]. Another hospital-based case-controlled study showed a reduced risk of stomach cancer from higher intake of mushrooms including <italic>Flammulina velutipes, Hypsizigus marmoreus, Corrinellus shiitake</italic> and <italic>Pholiota nameko</italic> [<xref rid="B71-molecules-26-00251" ref-type="bibr">71</xref>]. Lastly, a superfine dispersed lentinan (SDL) oral formulation was evaluated on advanced colorectal cancer. Lentinan is an immunomodulatory &#x003b2;-glucan isolated from <italic>L. edodes.</italic> Eighty patients with advanced colorectal cancer were administered with 15 mg dose per day of SDL for 12 weeks. The SDL formulation, found to be safe and efficacious, reduced the adverse effects of chemotherapy and was associated with increasing the quality of life of patients with advanced colorectal cancer [<xref rid="B72-molecules-26-00251" ref-type="bibr">72</xref>].</p></sec></sec><sec id="sec3dot3-molecules-26-00251"><title>3.3. Anti-Inflammatory Activity</title><sec id="sec3dot3dot1-molecules-26-00251"><title>3.3.1. Anti-Inflammatory Activity In-Vitro</title><p>Mushrooms native to North America have also been explored for anti-inflammatory activity. Out of 29 species examined from north-central BC [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>] and Haida Gwaii [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>], 26 species (69%) had their anti-inflammatory activity reported for the first time. These species include <italic>A. augusta, C. tomentosus, Clavulina cinerea, G. helvelloides, G. esculenta, Hydnellum repandum, Hygrophoropsis aurantiaca, Hypholoma fasciculare, Inocybe sp., L. conifericola, L. connate, Phellinus nigricans, P. atratus, P. ostreatus, R. cystidiophora, R. paludosa, T. abietinum, T. rutilans,</italic> and <italic>T. chioneus</italic>. Extracts from <italic>I. obliquus</italic> collected in BC, like those found in other parts of the world, showed strong anti-inflammatory activity in vitro. Polymyxin B was used as positive control to assess anti-inflammatory activity [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>,<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]. In another study conducted on North American mushrooms, 95% ethanol extracts of <italic>Elaphomyces granulatus, Rhizopogon nigrescens</italic>, and <italic>Scleroderma laeve</italic> possessed strong anti-inflammatory activity whereas <italic>E. muricatus, Hymenogaster subalpinus, Melanogaster tuberiformis, Rhizopogon couchii, R. subaustralis,</italic> and <italic>R. subgelatinosus</italic> were also active against inflammation. COX-2 activity was assessed to determine the anti-inflammatory potential and NS-0398 was used as a positive control [<xref rid="B25-molecules-26-00251" ref-type="bibr">25</xref>]. A limited number of anti-inflammatory compounds have been isolated from mushrooms native to North America. A 5 kDa polysaccharide isolated from the NaOH extract of North American mushroom <italic>E. tinctorium</italic> was able to induce anti-inflammatory response in Raw264.7 macrophage cells [<xref rid="B18-molecules-26-00251" ref-type="bibr">18</xref>]. A polysaccharide called CDP from <italic>Gymnopus dryophilus</italic> [<xref rid="B31-molecules-26-00251" ref-type="bibr">31</xref>], and CDP-like polysaccharides from <italic>L. edodes</italic> and <italic>Marasmius oreades</italic> [<xref rid="B32-molecules-26-00251" ref-type="bibr">32</xref>], can inhibit nitric oxide production in Raw264.7 macrophage cells. Elsewhere, the ethanolic extract as well as two small molecules, syringaldehyde and syringic acid, isolated from <italic>E. granulatus</italic> inhibited COX-2 enzyme in Raw264.7 cells [<xref rid="B29-molecules-26-00251" ref-type="bibr">29</xref>]. The extract caused 68% inhibition of COX-2 at 50 &#x003bc;g/mL, whereas syringaldehyde and syringic acid were effective with IC50 of 3.5 &#x003bc;g/mL and 0.4 &#x003bc;g/mL respectively. The COX-2 inhibition of small molecules was compared with a positive control, NS-398, a known COX-2 inhibitor with IC50 of 0.2 &#x003bc;g/mL (0.64 &#x003bc;M) [<xref rid="B29-molecules-26-00251" ref-type="bibr">29</xref>].</p></sec><sec id="sec3dot3dot2-molecules-26-00251"><title>3.3.2. Anti-Inflammatory Activity in Animal Models</title><p>Currently, there are very limited studies examining the anti-inflammatory potential of North American mushrooms using animal models. In one study, the polysaccharide AIPetinc isolated from <italic>E. tinctorium</italic> showed anti-inflammatory activity on histamine-induced inflammatory mouse microcirculation model (<italic>n</italic> = 10 mice) [<xref rid="B18-molecules-26-00251" ref-type="bibr">18</xref>]. An intra-vital mouse model was used to determine acetylcholine-induced vasodilation, which is one of the events in inflammation. AIPetinc was able to induce nitric oxide production, reversed the response to histamine and restored the vascular integrity, thereby resulting in anti-inflammatory response [<xref rid="B18-molecules-26-00251" ref-type="bibr">18</xref>]. To determine the significance of the anti-inflammatory activity of AIPetinc, it should be further evaluated in other animal models. In another study, the methanol extracts of <italic>I. obliquus</italic> was found to attenuate histamine-induced inflammation conducted vasodilation in arterioles in the gluteus muscle of mice (<italic>n</italic> = 41) [<xref rid="B34-molecules-26-00251" ref-type="bibr">34</xref>]. Anti-inflammatory compounds ergosterol, ergosterol peroxide and trametenolic acid had been isolated from the sclerotia of <italic>I. obliquus</italic> available from Haerbin, China [<xref rid="B73-molecules-26-00251" ref-type="bibr">73</xref>]. It is unknown whether these compounds are present in the wild <italic>I. obliquus</italic> from B.C. and were responsible for attenuating histamine-induced inflammation in the gluteus muscle mouse model [<xref rid="B34-molecules-26-00251" ref-type="bibr">34</xref>].</p></sec><sec id="sec3dot3dot3-molecules-26-00251"><title>3.3.3. Anti-Inflammatory Activity in Clinical Studies</title><p>Given that there had been only two animal studies as described above, it is not surprising that there are currently no clinical studies examining anti-inflammatory potential of mushrooms North America. However, we wish to draw readers&#x02019;attention to another review article that has summarized clinical studies alongside in-vitro and animal studies on investigating anti-inflammatory properties of mushrooms [<xref rid="B74-molecules-26-00251" ref-type="bibr">74</xref>].</p></sec></sec><sec id="sec3dot4-molecules-26-00251"><title>3.4. Immuno-Stimulatory Activity</title><sec id="sec3dot4dot1-molecules-26-00251"><title>3.4.1. <italic>Immuno-Stimulatory</italic> Activity In-Vitro</title><p>Mushroom species are known to have immunotherapeutic properties and over 270 species had been recognized for such medicinal potential [<xref rid="B75-molecules-26-00251" ref-type="bibr">75</xref>]. Mushrooms are natural immune modulators that can enhance the host immune system by activating dendritic cells, T cells, NK cells, macrophages, and cytokines. Mushroom native to North America have also been explored for immuno-stimulatory activity. Out of 29 species of mushrooms examined from north-central BC [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>] and Haida Gwaii, BC [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>], 20 species exhibited immuno-stimulatory activity. Fifteen out of the 20 species (75%) had their immuno-stimulatory activity reported for the first time [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>,<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]. These species include <italic>A. augusta, C. tomentosus, C. cinerea, F. fomentarius, G. helvelloides, G. esculenta, Hericium corralloides, H. repandum, Hydnellum</italic> sp.<italic>, H. aurantica, H. fasciculare, Inocybe</italic> sp<italic>., L. conifericola, L. connata, P. nigricans, P. atratus,</italic> and <italic>Piptoporus betulinus</italic>.</p><p>To date, most of the immuno-stimulatory compounds from mushrooms are polysaccharides or polysaccharide-protein complexes [<xref rid="B76-molecules-26-00251" ref-type="bibr">76</xref>,<xref rid="B77-molecules-26-00251" ref-type="bibr">77</xref>]. Due to problems such as: (i) high variability of polysaccharides that is further exacerbated during extraction and purification, (ii) impurities and contaminants, and (iii) difficulty in defining the structure and chemical fingerprint to understand structure-function relationships [<xref rid="B78-molecules-26-00251" ref-type="bibr">78</xref>], there has been little interest amongst scientists in North America to study and isolate immuno-stimulatory polysaccharides from mushrooms native to North America.</p></sec><sec id="sec3dot4dot2-molecules-26-00251"><title>3.4.2. <italic>Immuno-Stimulatory</italic> Activity in Animal Models</title><p>There is currently no animal studies examining the immuno-stimulatory activity of mushrooms native to North America. However, there were many animal studies evaluating the immuno-stimulatory effects of mushrooms collected elsewhere [<xref rid="B11-molecules-26-00251" ref-type="bibr">11</xref>]. For instance, there were animal studies examining immunomodulatory activity of <italic>G. lucidum</italic> and its related species, <italic>G. tsugae</italic> and <italic>G. applanatum</italic> [<xref rid="B79-molecules-26-00251" ref-type="bibr">79</xref>]. In another study, Agarikon 1 and Agarikon Plus which contains medicinal mushroom mixtures, were found to activate and maintain the immune system equilibrium in an advanced colorectal mouse model [<xref rid="B80-molecules-26-00251" ref-type="bibr">80</xref>]. Elsewhere, the hot water, methanol and polysaccharide extracts of <italic>Lentinula edodes</italic> induced immune response against eimeriasis in chicken [<xref rid="B81-molecules-26-00251" ref-type="bibr">81</xref>].</p></sec><sec id="sec3dot4dot3-molecules-26-00251"><title>3.4.3. <italic>Immuno-Stimulatory</italic> Activity in Clinical Studies</title><p>As with animal studies, there is currently no clinical studies evaluating the immuno-stimulatory effect of North American mushrooms. There are also limited clinical studies evaluating immuno-potentiating effects of mushrooms collected from elsewhere. Two of the most notable medicinal mushrooms. <italic>T. versicolor</italic> and <italic>Grifola frondosa</italic> (Maitake mushroom), had been clinically investigated for such purposes. As described in 3.2.3, both PSP and PSK are immuno-potentiating anticancer polysaccharides isolated from <italic>T. versicolor</italic> that had undergone many clinical studies and this has been critically reviewed recently [<xref rid="B11-molecules-26-00251" ref-type="bibr">11</xref>]. For <italic>G. frondosa</italic>, its polysaccharide extract was administered to 34 breast cancer patients on a phase I/II clinical trial. Cytokine analysis in patients&#x02019; peripheral blood showed signs of both immuno-stimulatory and &#x02013;inhibitory effects [<xref rid="B82-molecules-26-00251" ref-type="bibr">82</xref>]. There was no dose-limiting toxicity observed in patients, suggesting that the extract is safe. The authors concluded that the <italic>G. frondosa</italic> polysaccharide should be classified as immuno-modulatory rather than immuno-stimulatory.</p></sec></sec><sec id="sec3dot5-molecules-26-00251"><title>3.5. Anti-Oxidant Activity</title><sec id="sec3dot5dot1-molecules-26-00251"><title>3.5.1. Anti-Oxidant Activity In-Vitro</title><p>There has been relatively less study on anti-oxidant activity of mushrooms native to North America. One study reported ethanolic extracts from 11 species of mushrooms collected from Idaho, Oregon, and New Jersey, to have moderate to weak anti-oxidant activity. In the study, 70&#x02013;95% ethanolic extracts of various mushrooms were assessed and Vitamin C was used as a positive control [<xref rid="B25-molecules-26-00251" ref-type="bibr">25</xref>]. <italic>Scleroderma laeve</italic> showed strong anti-oxidant activity with an IC50 of less than 20 &#x003bc;g/mL whereas <italic>Rhizopogon pedicellus</italic>, <italic>R. couchii, Leucogaster rubescens,</italic> and <italic>Geopora clausa</italic> had moderate anti-oxidant effect with IC50 of 20&#x02013;50 &#x003bc;g/mL. <italic>Elaphomyces granulatus, E. muricatus, Gautieria monticola, Melanogaster tuberiformis, Rhizopogon nigrescens,</italic> and <italic>R. subaustralis</italic> had weak anti-oxidant activity with IC<sub>50</sub> values of more than 50 &#x003bc;g/mL [<xref rid="B25-molecules-26-00251" ref-type="bibr">25</xref>].</p><p>The ethanolic extract as well as syringic acid isolated from the fruiting bodies of <italic>Elaphomyces granulatus</italic> showed potent antioxidant effect on myelomonocytic HL-60 cells with an IC50 of 41 &#x003bc;g/mL for the extract and 0.7 &#x003bc;g/mL for syringic acid. Vitamin C was used as a positive control with IC50 of 0.5 &#x003bc;g/mL (2.84 &#x003bc;M) to compare the anti-oxidant activity of syringic acid and ethanol extracts [<xref rid="B29-molecules-26-00251" ref-type="bibr">29</xref>]. This study shows the promising effects of syringic acid as a potent anti-oxidant and can be considered for drug development. Two edible mushrooms, <italic>P. ostreatus</italic> from USA and <italic>P. levis</italic> from Mexico, also showed antioxidant activity. The effective concentration (EC-50) was also determined via DPPH free radical scavenging assay, ABTS scavenging assay, and &#x003b2;-carotene linoleic acid assays where BHA, BHT, &#x003b1;-tocopherol, and ascorbic acid were used as standards [<xref rid="B39-molecules-26-00251" ref-type="bibr">39</xref>]. The anti-oxidant activity was also determined by oxygen radical absorbance capacity assay and the anti-oxidant effect was compared with a known anti-oxidant, Trolox, a vitamin E analog [<xref rid="B39-molecules-26-00251" ref-type="bibr">39</xref>].</p></sec><sec id="sec3dot5dot2-molecules-26-00251"><title>3.5.2. Anti-Oxidant Activity in Animal Models</title><p>As with the immuno-stimulatory activity, there is currently no study on the evaluation of North American mushrooms for anti-oxidant activity in animal models. However, there were animal studies investigating the anti-oxidant effect of medicinal mushrooms collected elsewhere. For instance, since oxidative stress plays important role in the etiology of diabetes, the impact of mushrooms on antioxidant enzymes involved in streptozotocin-induced diabetes were investigated in mouse models [<xref rid="B83-molecules-26-00251" ref-type="bibr">83</xref>,<xref rid="B84-molecules-26-00251" ref-type="bibr">84</xref>]. The effect of administration of G. lucidum and Agaricus brasiliensis were studied in rat leukocytes. Streptozotocin was administered intraperitoneally at 50 mg/kg body weight to induce diabetes whereas mushrooms were given orally at a dose of 1 g/kg every day for 2 weeks. Mushroom preparations were found to increase the activity of anti-oxidant enzymes [<xref rid="B83-molecules-26-00251" ref-type="bibr">83</xref>]. Another study also determined the anti-oxidant enzymes protection by mycelia of the two mushrooms on rat erythrocytes after induction of diabetes by streptozotocin [<xref rid="B84-molecules-26-00251" ref-type="bibr">84</xref>]. In another separate study, anti-oxidant effect and regulation of lipid metabolism by <italic>F. velutipes</italic> extracts was studied. Forty eight hamsters were divided into eight groups, six hamsters/group, where one group was given normal diet while others were given high fat diet. 1&#x02013;3% of mushroom preparation was added to their diet for 8 weeks, which resulted in significant effect on lipid metabolism of hamsters with high fat diet [<xref rid="B85-molecules-26-00251" ref-type="bibr">85</xref>].</p></sec></sec><sec id="sec3dot6-molecules-26-00251"><title>3.6. Anti-Fungal Activity</title><p>Many mushrooms are known to possess antifungal activity [<xref rid="B86-molecules-26-00251" ref-type="bibr">86</xref>]. However, there has been only one study on anti-fungal activity of mushroom native to North America. A study shows that a chlorinated orcinol derivative, 2-chloro-1,3-dimethoxy-5-methyl benzene isolated from mycelial cultures of <italic>Hericium</italic> sp. collected in Minnesota (USA), showed inhibitory effect on <italic>Candida albicans</italic> and <italic>Candida neoformans</italic>, suggesting its role as an antifungal agent [<xref rid="B17-molecules-26-00251" ref-type="bibr">17</xref>]. <italic>Hericium sp</italic>. is an edible mushroom containing multiple small molecules, making it an attractive option for further screening.</p></sec><sec id="sec3dot7-molecules-26-00251"><title>3.7. Other Bioactivities</title><p>In addition to the bioactivities described above, mushrooms from North America have also been investigated for antiparasitic, antimalarial and antituberculosis activities. A study conducted in Mexico showed antiparasitic effects of hydroalcoholic extracts from <italic>Pleurotus djamor</italic> against <italic>Haemonchus contortus</italic> eggs [<xref rid="B38-molecules-26-00251" ref-type="bibr">38</xref>], suggesting its metabolites can act as anthelmintics. In the same study, few small molecules with antiparasitic activity were also isolated [<xref rid="B38-molecules-26-00251" ref-type="bibr">38</xref>]. Stanikunaite and co-workers assessed 22 species of mushrooms native to North America and found <italic>Rhizopogon subareolatus</italic> to have antimalarial activity [<xref rid="B25-molecules-26-00251" ref-type="bibr">25</xref>]. They also found the following species to have antituberculosis activity: <italic>Astraeus pteridis, Barssia oregonensis, Elaphomyces granulatus, Elaphomyces muricatus, Hymenogaster subalpinus, Melanogaster tuberiformis, Rhizopogon couchii, Rhizopogon pedicellus, Rhizopogon subareolatus,</italic> and <italic>Scleroderma leave</italic> [<xref rid="B25-molecules-26-00251" ref-type="bibr">25</xref>].</p></sec></sec><sec id="sec4-molecules-26-00251"><title>4. Bioactive Compounds from Mushrooms Native to North America</title><p>Since there is relatively limited number of studies on mushrooms native to North America, it is not surprising to find relatively limited number of bioactive compounds isolated from the mushrooms. Here, we summarize all the bioactive compounds that have been isolated from mushrooms native to North America into two general groups, large molecules and small molecules (<xref rid="molecules-26-00251-t002" ref-type="table">Table 2</xref>) (<xref ref-type="fig" rid="molecules-26-00251-f001">Figure 1</xref>).</p><sec id="sec4dot1-molecules-26-00251"><title>4.1. Large Molecular Weight Compounds</title><p>Large molecular weight compounds isolated from mushrooms are typically homo- and heteroglycans, proteins, polysaccharide-protein complexes and nucleic acids-protein complexes (<xref ref-type="fig" rid="molecules-26-00251-f001">Figure 1</xref>) [<xref rid="B87-molecules-26-00251" ref-type="bibr">87</xref>]. <xref rid="molecules-26-00251-t002" ref-type="table">Table 2</xref> summarizes the bioactive large molecules that have been isolated from North American wild mushrooms. A 229 kDa growth-inhibitory heteroglycan GIPinv was isolated from the 5% NaOH extract of <italic>P. involutus</italic> [<xref rid="B87-molecules-26-00251" ref-type="bibr">87</xref>]. GIPinv is made up predominantly of glucose (65.9%), galactose (20.8%) and mannose (7.8%) with traces of fucose (3.2%) and xylose (2.3%) [<xref rid="B31-molecules-26-00251" ref-type="bibr">31</xref>]. It has mixed linkages in the backbone containing (1&#x02192;6)-Gal, (1&#x02192;4)-Glc, (1&#x02192;6)-Glc, (1&#x02192;3)-Glc, and (1&#x02192;2)-Xyl, with branching points at (1&#x02192;2,6)-Man and (1&#x02192;3,6)-Man. Another growth-inhibitory polysaccharide, an exopolysaccharide called EPS, was isolated from <italic>P. tuber-regium</italic> [<xref rid="B51-molecules-26-00251" ref-type="bibr">51</xref>]. EPS is 3,180 kDa and consisted mainly of mannose (57.5%) and glucose (42.5%). Another study showed anti-proliferative effect of a 12 kDa 130-amino acid containing glycan binding protein (Y3). Y3 is a tertiary protein isolated from <italic>Coprinus comatus</italic> and exhibited selective anti-proliferative effects in human T cell leukemia Jurkat cells [<xref rid="B28-molecules-26-00251" ref-type="bibr">28</xref>].</p><p>A 1234 kDa anti-inflammatory &#x003b2;-glucan polysaccharide CDP consisting of (1&#x02192;3) and (1&#x02192;4) glucosidic linkages was isolated from aqueous extract of the fruiting bodies of <italic>G. dryophilus</italic> [<xref rid="B31-molecules-26-00251" ref-type="bibr">31</xref>,<xref rid="B32-molecules-26-00251" ref-type="bibr">32</xref>]. The authors treated mouse macrophage Raw 264.7 cells with 50 to 1000 &#x003bc;g/mL of CDP and showed that it had no toxicity effects [<xref rid="B32-molecules-26-00251" ref-type="bibr">32</xref>]. Some other CDP-like polysaccharides 610 kDa and 1316 kDa in size with anti-inflammatory potential were isolated from the aqueous extracts of <italic>L. edodes</italic> and <italic>Marasmius oreades</italic> respectively [<xref rid="B32-molecules-26-00251" ref-type="bibr">32</xref>]. In the same study, water-soluble CDP-like polysaccharides were also isolated from multiple mushrooms obtained from Quebec (Canada). These include <italic>Agaricus arvensis</italic>, <italic>Tricholoma flavovirens</italic>, <italic>Suillus americanus</italic>, <italic>Amanita muscaria</italic>, <italic>Amanita rubescens</italic>, <italic>Lycoperdon pyriforme</italic>, <italic>Coprinus atramentarius</italic>, <italic>C. comatus</italic>, <italic>Hydnum imbricatum</italic>, <italic>Lactarius deliciosus</italic>, <italic>Leccinum aurantiacum</italic>, <italic>Leccinum subglabripes</italic>, <italic>Lepiota americana</italic>, <italic>Panellus serotinus</italic>, <italic>P. betulinus</italic>, <italic>Polyporus squamosus</italic>, <italic>Russula variata</italic>, and <italic>T. vaccinum</italic> [<xref rid="B32-molecules-26-00251" ref-type="bibr">32</xref>]. Another relatively small 5 kDa &#x003b2;-glucan called AlPetinc with anti-inflammatory activity was isolated from the 5% NaOH extract of <italic>E. tinctorium</italic> [<xref rid="B18-molecules-26-00251" ref-type="bibr">18</xref>]. AlPetinc is a heteroglucan composed mainly of glucose (88.6%) with a small amount of mannose (4.4%), galactose (4.0%), xylose (2.3%), and fucose (0.7%).</p><p>As mentioned briefly in <xref ref-type="sec" rid="sec3dot4-molecules-26-00251">Section 3.4</xref>, there has been a lack of interest amongst scientists in the West, especially in North America, in studying bioactive polysaccharides for use as medicinal compounds [<xref rid="B78-molecules-26-00251" ref-type="bibr">78</xref>]. However, with recent advances in identifying biosynthetic gene clusters and transcriptomic studies including those in fungi, it is now possible to produce compounds including large polysaccharides using heterologous expression systems by genetic engineering [<xref rid="B88-molecules-26-00251" ref-type="bibr">88</xref>,<xref rid="B89-molecules-26-00251" ref-type="bibr">89</xref>,<xref rid="B90-molecules-26-00251" ref-type="bibr">90</xref>,<xref rid="B91-molecules-26-00251" ref-type="bibr">91</xref>]. Such efforts are expected to enable large scale production of pure bioactive polysaccharides, thereby overcoming some if not all of the problems previously encountered [<xref rid="B78-molecules-26-00251" ref-type="bibr">78</xref>].</p></sec><sec id="sec4dot2-molecules-26-00251"><title>4.2. Small Molecules</title><p>Small molecules that had been isolated from mushrooms include quinones, cerebrosides, amines, catechols, sesquiterpenes, triacylglycerols, steroids, organic germanium, and selenium (<xref ref-type="fig" rid="molecules-26-00251-f001">Figure 1</xref>) [<xref rid="B87-molecules-26-00251" ref-type="bibr">87</xref>]. Amongst the handful of small molecules isolated from North American mushrooms, few are terpene derivatives as shown in <xref rid="molecules-26-00251-t002" ref-type="table">Table 2</xref> and <xref ref-type="fig" rid="molecules-26-00251-f002">Figure 2</xref>.</p><p>Two small molecules, syringaldehyde and syringic acid with molar mass of 182 g/mol and 198 g/mol respectively, were isolated from ethanol extract of the fruiting bodies of <italic>E. granulatus</italic> [<xref rid="B29-molecules-26-00251" ref-type="bibr">29</xref>]. The possible toxicity of both compounds was evaluated on macrophage Raw 264.7 cells and HL-60 cells. The authors found that both syringaldehyde and syringic acid had no effect on Raw 264.7 and HL-60 cells viability of up to 25 &#x003bc;g/mL and 31.25 &#x003bc;g/mL respectively [<xref rid="B29-molecules-26-00251" ref-type="bibr">29</xref>]. Grifolin (328 g/mol), neogrifolin (328 g/mol) and confluentin (326 g/mol) with growth-inhibitory and antibacterial activities were isolated from the ethanol extract of the fruiting bodies of <italic>A. flettii</italic> [<xref rid="B21-molecules-26-00251" ref-type="bibr">21</xref>,<xref rid="B22-molecules-26-00251" ref-type="bibr">22</xref>]. A lanostane-type triterpene named 3, 11-dioxdanosta-8,24(Z)-diene-26-oic acid with molar mass of 468 g/mol was isolated from <italic>J. hirtus</italic>. This triterpene effectively inhibited the growth of two Gram positive bacteria; <italic>Bacillus cereus</italic> and <italic>Enterococcus faecalis</italic> [<xref rid="B21-molecules-26-00251" ref-type="bibr">21</xref>]. Three new bisnaphthalene subclass compounds called urnucratins A&#x02013;C were isolated from the North American cup fungus <italic>U. craterium</italic> [<xref rid="B41-molecules-26-00251" ref-type="bibr">41</xref>]. Urnucratin A (348 g/mol) was found to be active against methicillin-resistant <italic>Staphylococcus aureus</italic>, vanocymin-resistant <italic>Enterococcus faecium</italic> and <italic>Streptococcus pyogenes</italic> [<xref rid="B41-molecules-26-00251" ref-type="bibr">41</xref>]. A new lanostane triterpenoid named 3-oxo-24-methyl-5&#x003b1;-lanost-8,25-dien-21-oic acid (468 g/mol) with activity against <italic>B. cereus</italic> was isolated from <italic>F. pinicola</italic> native to North America [<xref rid="B30-molecules-26-00251" ref-type="bibr">30</xref>]. The same study also reported isolation of four known lanostane triterpenoids and one known ergostane steroid with anti-bacterial activity [<xref rid="B30-molecules-26-00251" ref-type="bibr">30</xref>].</p><p>Many small molecules were isolated from <italic>Hericium</italic> sp. which included two new compounds, an erinacerin V alkaloid with molar mass of 257 g/mol and an aldehyde derivative of 4-hydroxychroman, 4-chloro-3,5-dimethoxybenzaldehyde with molar mass of 206 g/mol [<xref rid="B17-molecules-26-00251" ref-type="bibr">17</xref>]. Seven known compounds were also isolated from <italic>Hericium</italic> sp. which included 2-chloro-1,3-dimethoxy-5-methylbenzene, (4-chloro-3,5-dimethoxyphenyl) methanol, 3,6-bis(hydroxymethyl)-2-methyl-4<italic>H</italic>-pyran-4-one, 4-chloro-3,5-dimethoxybenzoic acid, 5-hydroxy-6-(1-hydroxyethyl)isobenzofuran-1(3<italic>H</italic>)-one, and erinacine [<xref rid="B17-molecules-26-00251" ref-type="bibr">17</xref>]. Some other small molecules that had been isolated from North American mushrooms include pentadecanoic acid, hexadecanoic acid, 2<italic>E</italic>,4<italic>E</italic>-octadecadienoic acid, and octadecanoic acid from <italic>Pleurotus djamor</italic> [<xref rid="B38-molecules-26-00251" ref-type="bibr">38</xref>], and orenalline from <italic>Cortinarius armillatus</italic> [<xref rid="B19-molecules-26-00251" ref-type="bibr">19</xref>]. Most of these compounds have not been assessed for bioactivity and toxicity except orenalline. There were many studies on evaluating the toxicity of orenalline which is considered a nephrotoxin [<xref rid="B20-molecules-26-00251" ref-type="bibr">20</xref>]. Four new compounds belonging to the butenolide groups called ramariolides A&#x02013;D were isolated from the coral mushroom <italic>Ramaria cystidiophora</italic> collected in southwestern British Columbia (Canada) [<xref rid="B50-molecules-26-00251" ref-type="bibr">50</xref>]. Ramariolides A was found to have antimicrobial activity against <italic>Mycobacterium smegmatis</italic> and <italic>Mycobacterium tuberculosis</italic> [<xref rid="B50-molecules-26-00251" ref-type="bibr">50</xref>].</p></sec></sec><sec id="sec5-molecules-26-00251"><title>5. Mushrooms from North America as a Source for Drug Discovery</title><p>As shown in <xref rid="molecules-26-00251-t001" ref-type="table">Table 1</xref>, to date 79 species of mushrooms native to North America had been investigated and exhibited medicinal properties. Out of these, 48 species (60%) have bioactivities that have not been previously reported (<xref rid="molecules-26-00251-t001" ref-type="table">Table 1</xref>). These include <italic>A. augusta</italic> with strong anti-proliferative activity, <italic>G. dryophilus</italic> with anti-inflammatory activity, <italic>G. esculenta</italic> with strong immunostimulatory activity, and <italic>H. coralloides</italic> with strong immuno-stimulatory activity [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>,<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]. This also includes <italic>C. tomentosus, G. helvelloides, L. conifericola, L. connata, T. abietinum</italic> with strong activity in antiproliferation, immunostimulation and anti-inflammation [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>,<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]. There were specimens that could only be identified to the genus level, <italic>Inocybe</italic> sp. and <italic>Hydnellum</italic> sp., suggesting that they are new species. <italic>Inocybe</italic> sp. showed strong anti-proliferative, immuno-stimulatory and anti-inflammatory activities, while <italic>Hydnellum</italic> sp. exhibited strong anti-proliferative activity [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]. There were 13 species that had been studied elsewhere, but their new bioactivities were discovered in the species collected in North America (<xref rid="molecules-26-00251-t001" ref-type="table">Table 1</xref>). This includes <italic>Haploporus odorus</italic> with antimicrobial activity; <italic>C. cinerea, H. repandum, H. aurantiaca, H. fasciculare, P. nigricans,</italic> and <italic>P. ostreatus</italic> with anti-inflammatory activity; <italic>R. cystidiophora, R. paludosa, T. rutilans,</italic> and <italic>T. chioneus</italic> with anti-proliferative and anti-inflammatory activities.</p><p>As shown in <xref rid="molecules-26-00251-t002" ref-type="table">Table 2</xref>, there has been very limited number of studies exploring bioactive compounds from North American mushrooms. Despite the limited number of studies, 10 new small molecules, six new polysaccharides and a new protein with bioactivity have been discovered (<xref rid="molecules-26-00251-t002" ref-type="table">Table 2</xref>).</p><p>Such observations and the fact that a large number of mushrooms native to North America having bioactivities that have never been previously described, strongly suggests that North American mushrooms are indeed a good source for drug discovery.</p></sec><sec id="sec6-molecules-26-00251"><title>6. Edibility of Mushrooms Native to North America</title><p>North American mushrooms offer a wide variety of medicinal benefits and some have been appreciated for their exquisite flavors. While some are unique and edible, others are toxic for human consumption. Edible mushrooms are valuable as functional foods. Nonetheless, both edible and non-edible mushrooms offer great benefits against diseases. Edibility of mushrooms is an important attribute that allows them to be used as functional foods and potential phytomedicines. Like elsewhere, many edible mushrooms are found in North America. Here, we only highlight some of the popular ones. Some of the North American edible mushrooms [<xref rid="B92-molecules-26-00251" ref-type="bibr">92</xref>,<xref rid="B93-molecules-26-00251" ref-type="bibr">93</xref>] with medicinal properties are <italic>A flettii, I obliquus (Chaga), G. dryophilus, C. comatus, L. edodes</italic> (Shiitake)<italic>, Marasmius oreades</italic> (fairy ring mushroom)<italic>, Boletus curtisii,</italic> and <italic>Amanita augusta</italic>. Most mushrooms that belong to the <italic>Pleurotus</italic> genus are also edible and they include <italic>P. tuberregium</italic>, <italic>P. djamor, P. ostreatus</italic>, and <italic>P. levis</italic>. <italic>G. helvelloides</italic> is edible but it is rather bland and is therefore not much preferred in culinary. One of the most popular wild edible mushrooms in North America is chanterelle [<xref rid="B85-molecules-26-00251" ref-type="bibr">85</xref>]. There are over 70 species of chanterelles (<italic>Cantharellus</italic> spp.) described worldwide and the most sought-after in North America is the Pacific golden chanterelle (<italic>Cantharellus formosa</italic>) found from northern California to northern BC [<xref rid="B94-molecules-26-00251" ref-type="bibr">94</xref>]. Another popular culinary mushroom in North America as well as in Europe is <italic>Morchella</italic>, the true morels. At least 19 species of <italic>Morchella</italic> had been identified in North America [<xref rid="B95-molecules-26-00251" ref-type="bibr">95</xref>] with black morels (<italic>Morchella elata</italic> and related species) found in Washington State and BC being one of the most highly demand culinary mushrooms. Lastly, the wild edible lobster mushroom (<italic>Hypomyces lactifluorum/Russula brevipes</italic>), uniquely confined to North America, is not a species but the result from infection of <italic>Russula</italic> (mostly <italic>Russula brevipes</italic>) or <italic>Lactarius</italic> genera by <italic>Hypomyces lactifluorum</italic> parasite [<xref rid="B96-molecules-26-00251" ref-type="bibr">96</xref>]. The lobster mushroom, widely distributed in northern parts of United States and in Canada, has a seafood-like flavor and is enjoyed by many locals.</p><p>North American medicinal mushrooms that are considered toxic or non-edible [<xref rid="B92-molecules-26-00251" ref-type="bibr">92</xref>,<xref rid="B93-molecules-26-00251" ref-type="bibr">93</xref>] for general human consumption can be tailored as drugs after sufficient toxicity testing and targeted dosage form development. Some of the features that make mushrooms inedible are the presence of toxic metabolites in the whole mushroom, its taste and toughness. <italic>E. tinctorium</italic> is a hard, inedible conk. <italic>P. atratus</italic> and <italic>J. hirtus</italic> are also tough mushrooms and apparently <italic>J. hirtus</italic> has bitter taste. <italic>P. involutus</italic> is considered poisonous for human use. <italic>E. granulatus</italic> is also non-edible. At high doses, <italic>C. armillatus</italic> is considered toxic due to the presence of orenalline [<xref rid="B19-molecules-26-00251" ref-type="bibr">19</xref>], a potent nephrotoxin originally isolated from <italic>Cortinarius orellanus</italic> [<xref rid="B97-molecules-26-00251" ref-type="bibr">97</xref>]. Therefore, it is possible that orenalline is present at low amount in <italic>C. armillatus.</italic></p></sec><sec sec-type="conclusions" id="sec7-molecules-26-00251"><title>7. Conclusions</title><p>Having extensively reviewed the literature on the bioactivities and compounds isolated from mushrooms native to North America, we can now attempt to answer the questions posed at the beginning of this review. (i) Do similar species found in North America and elsewhere exhibit similar bioactivities and produce similar group of bioactive compounds? Based on subjective approach of bioactivity-guided investigations on selective species, similar species found in North America and elsewhere indeed produce similar bioactivities. For example, this is true for the commonly <italic>studied I. obliquus and P. ostreatus</italic>. Furthermore, compounds such as grifolin, neogrifolin and confluentin produced in North American <italic>A. flettii</italic>, are also made by other <italic>Albatrellus</italic> genus found elsewhere [<xref rid="B21-molecules-26-00251" ref-type="bibr">21</xref>,<xref rid="B22-molecules-26-00251" ref-type="bibr">22</xref>]. However, a better answer can only be obtained by using more advanced and objective method such as Quadruple Time-of-Flight Mass Spectrometry to globally examine the metabolites produced and using multiple biological screening assays to simultaneously monitor different bioactivities. (ii) Do similar species found in North America and elsewhere exhibit distinct bioactivity and produce distinct compounds? Again, the answer to this question would come from more advanced approaches described above. (iii) Do new species found in North America produce new compound(s)? Due to limited number of studies on mushrooms native to North America, it is currently unknown whether new species found in North America produce new compound(s). However, based on very limited study (<xref rid="molecules-26-00251-t002" ref-type="table">Table 2</xref>), it is likely that new medicinal compounds are produced by new species found in North America. (iv) Based on the answers to (i) to (iii) above, is it worth exploring mushrooms native to North America for medicinal properties and for new compounds? We believe that North American mushrooms are worth further exploration. This is based on the fact that there are many species, including new species, in North America whose bioactivities have never been previously reported (<xref rid="molecules-26-00251-t001" ref-type="table">Table 1</xref>). Furthermore, novel compounds have been isolated from North American mushrooms despite the very limited number of studies (<xref rid="molecules-26-00251-t002" ref-type="table">Table 2</xref>).</p><p>In summary, to date only 79 mushroom species in North America that have been studied and reported to possess medicinal properties. Of these, 48 species (60%) exhibited bioactivities that have never been previously reported (<xref rid="molecules-26-00251-t001" ref-type="table">Table 1</xref>). To date, only 16 mushroom species in North America that had been subjected to bioactivity-guided compound isolation studies. Out of this limited number of studies, already 10 new small molecules, 6 new polysaccharides and a new protein with medicinal properties have been discovered (<xref rid="molecules-26-00251-t002" ref-type="table">Table 2</xref>). For the majority of these compounds, studies are still at an early stage using cell lines, and their significance needs to be demonstrated in animal models and beyond.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>Both authors contributed to writing and editing of the manuscript. Both authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This work was supported by an NSERC Discovery Grant (Grant #227158), Canada Foundation for Innovation Grant (#34711), and a BC Development Fund Grant awarded to C.H.L. The APC was funded by MDPI.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-molecules-26-00251"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Chang</surname><given-names>S.T.</given-names></name><name><surname>Hayes</surname><given-names>W.A.</given-names></name></person-group><source>The Biology and Cultivation of Edible Mushrooms</source><publisher-name>Academic Press Inc.</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>1978</year><fpage>19</fpage></element-citation></ref><ref id="B2-molecules-26-00251"><label>2.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hawksworth</surname><given-names>D.L.</given-names></name><name><surname>L&#x000fc;cking</surname><given-names>R.</given-names></name></person-group><article-title>Chapter 4, Fungal diversity revisited: 2.2 to 3.8 million species</article-title><source>The Fungal Kingdom</source><person-group person-group-type="editor"><name><surname>Heitman</surname><given-names>J.</given-names></name><name><surname>Howlett</surname><given-names>B.J.</given-names></name></person-group><publisher-name>ASM Press</publisher-name><publisher-loc>Washington, DC, USA</publisher-loc><year>2017</year><fpage>79</fpage><lpage>95</lpage></element-citation></ref><ref id="B3-molecules-26-00251"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawksworth</surname><given-names>D.L.</given-names></name></person-group><article-title>Mushrooms: The extent of the unexplored potential</article-title><source>Int. J. Med. Mushrooms.</source><year>2001</year><volume>3</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1615/IntJMedMushr.v3.i2-3.60</pub-id></element-citation></ref><ref id="B4-molecules-26-00251"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wasser</surname><given-names>S.P.</given-names></name></person-group><article-title>Medicinal mushroom science: Current perspectives, advances, evidences, and challenges</article-title><source>Biomed. J.</source><year>2014</year><volume>37</volume><fpage>345</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.4103/2319-4170.138318</pub-id><pub-id pub-id-type="pmid">25179726</pub-id></element-citation></ref><ref id="B5-molecules-26-00251"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>S.T.</given-names></name></person-group><article-title>Global impact of edible and medicinal mushrooms on human welfare in the 21st century: Non green revolution</article-title><source>Int. J. Med. Mushrooms</source><year>1999</year><volume>1</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1615/IntJMedMushrooms.v1.i1.10</pub-id></element-citation></ref><ref id="B6-molecules-26-00251"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reshetnikov</surname><given-names>S.V.</given-names></name><name><surname>Tan</surname><given-names>K.K.</given-names></name></person-group><article-title>Higher Basidiomycota as a source of antitumor and immunostimulating polysaccharides</article-title><source>Int. J. Med. Mushrooms</source><year>2001</year><volume>3</volume><fpage>1</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1615/IntJMedMushr.v3.i4.80</pub-id></element-citation></ref><ref id="B7-molecules-26-00251"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Griensven</surname><given-names>L.J.</given-names></name></person-group><article-title>Culinary-medicinal mushrooms: Must action be taken?</article-title><source>Int. J. Med. Mushrooms</source><year>2009</year><volume>11</volume><fpage>281</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1615/IntJMedMushr.v11.i3.70</pub-id></element-citation></ref><ref id="B8-molecules-26-00251"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wasser</surname><given-names>S.P.</given-names></name><name><surname>Weis</surname><given-names>A.L.</given-names></name></person-group><article-title>Medicinal properties of substances occurring in higher basidiomycetes mushrooms: Current perspectives</article-title><source>Int. J. Med. Mushrooms</source><year>1999</year><volume>1</volume><fpage>31</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1615/IntJMedMushrooms.v1.i1.30</pub-id></element-citation></ref><ref id="B9-molecules-26-00251"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wasser</surname><given-names>S.P.</given-names></name></person-group><article-title>Medicinal mushroom science: History, current status, future trends, and unsolved problems</article-title><source>Int. J. Med. Mushrooms</source><year>2010</year><volume>12</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1615/IntJMedMushr.v12.i1.10</pub-id></element-citation></ref><ref id="B10-molecules-26-00251"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>W.</given-names></name><name><surname>Miao</surname><given-names>K.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Pan</surname><given-names>S.</given-names></name><name><surname>Dai</surname><given-names>Y.</given-names></name></person-group><article-title>Chemical diversity of biologically active metabolites in the sclerotia of <italic>Inonotus obliquus</italic> and submerged culture strategies for up-regulating their production</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2010</year><volume>87</volume><fpage>1237</fpage><lpage>1254</lpage><pub-id pub-id-type="doi">10.1007/s00253-010-2682-4</pub-id><pub-id pub-id-type="pmid">20532760</pub-id></element-citation></ref><ref id="B11-molecules-26-00251"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blagodatski</surname><given-names>A.</given-names></name><name><surname>Yatsunskaya</surname><given-names>M.</given-names></name><name><surname>Mikhailova</surname><given-names>V.</given-names></name><name><surname>Tiasto</surname><given-names>V.</given-names></name><name><surname>Kagansky</surname><given-names>A.</given-names></name><name><surname>Katanaev</surname><given-names>V.L.</given-names></name></person-group><article-title>Medicinal mushrooms as an attractive new source of natural compounds for future cancer therapy</article-title><source>Oncotarget</source><year>2018</year><volume>9</volume><fpage>29259</fpage><lpage>29274</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.25660</pub-id><pub-id pub-id-type="pmid">30018750</pub-id></element-citation></ref><ref id="B12-molecules-26-00251"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanova</surname><given-names>T.S.</given-names></name><name><surname>Krupodorova</surname><given-names>T.A.</given-names></name><name><surname>Barshteyn</surname><given-names>V.Y.</given-names></name><name><surname>Artamonova</surname><given-names>A.B.</given-names></name><name><surname>Shlyakhovenko</surname><given-names>V.A.</given-names></name></person-group><article-title>Anticancer substances of mushroom origin</article-title><source>Exp. Oncol.</source><year>2014</year><volume>36</volume><fpage>58</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">24980757</pub-id></element-citation></ref><ref id="B13-molecules-26-00251"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panda</surname><given-names>M.K.</given-names></name><name><surname>Paul</surname><given-names>M.</given-names></name><name><surname>Singdevsachan</surname><given-names>S.K.</given-names></name><name><surname>Tayung</surname><given-names>K.</given-names></name><name><surname>Das</surname><given-names>S.K.</given-names></name><name><surname>Thatoi</surname><given-names>H.</given-names></name></person-group><article-title>Promising anticancer therapeutics from mushrooms: Current findings and future perceptions</article-title><source>Curr. Pharm. Biotechnol.</source><year>2020</year><pub-id pub-id-type="doi">10.2174/1389201021666201008164056</pub-id><?supplied-pmid 33032507?><pub-id pub-id-type="pmid">33032507</pub-id></element-citation></ref><ref id="B14-molecules-26-00251"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ejike</surname><given-names>U.C.</given-names></name><name><surname>Chan</surname><given-names>C.J.</given-names></name><name><surname>Okechukwu</surname><given-names>P.N.</given-names></name><name><surname>Lim</surname><given-names>R.L.Y.</given-names></name></person-group><article-title>New advances and potentials of fungal immunomodulatory proteins for therapeutic purposes</article-title><source>Crit. Rev. Biotechnol.</source><year>2020</year><pub-id pub-id-type="doi">10.1080/07388551.2020.1808581</pub-id><?supplied-pmid 32854547?><pub-id pub-id-type="pmid">32854547</pub-id></element-citation></ref><ref id="B15-molecules-26-00251"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burk</surname><given-names>W.R.</given-names></name></person-group><article-title>Puffball usages among North American Indians</article-title><source>J. Ethnobiol.</source><year>1983</year><volume>3</volume><fpage>55</fpage><lpage>62</lpage></element-citation></ref><ref id="B16-molecules-26-00251"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanchette</surname><given-names>R.A.</given-names></name><name><surname>Compton</surname><given-names>B.D.</given-names></name><name><surname>Turner</surname><given-names>N.J.</given-names></name><name><surname>Gilbertson</surname><given-names>R.L.</given-names></name></person-group><article-title>Nineteenth century shaman grave guardians are carved <italic>Fomitopsis officinalis</italic> sporophores</article-title><source>Mycologia</source><year>1992</year><volume>84</volume><fpage>119</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1080/00275514.1992.12026114</pub-id></element-citation></ref><ref id="B17-molecules-26-00251"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>X.</given-names></name><name><surname>Gaascht</surname><given-names>F.</given-names></name><name><surname>Schmidt-Dannert</surname><given-names>C.</given-names></name><name><surname>Salomon</surname><given-names>C.E.</given-names></name></person-group><article-title>Discovery of antifungal and biofilm preventative compounds from mycelial cultures of a unique North American <italic>Hericium</italic> sp. fungus</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>963</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25040963</pub-id></element-citation></ref><ref id="B18-molecules-26-00251"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javed</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>W.M.</given-names></name><name><surname>Zeb</surname><given-names>M.</given-names></name><name><surname>Yaqoob</surname><given-names>A.</given-names></name><name><surname>Tackaberry</surname><given-names>L.E.</given-names></name><name><surname>Massicotte</surname><given-names>H.B.</given-names></name><name><surname>Egger</surname><given-names>K.N.</given-names></name><name><surname>Cheung</surname><given-names>P.C.K.</given-names></name><name><surname>Payne</surname><given-names>G.W.</given-names></name><name><surname>Lee</surname><given-names>C.H.</given-names></name></person-group><article-title>Anti-inflammatory activity of the wild mushroom, <italic>Echinodontium tinctorium</italic>, in RAW264. 7 macrophage cells and mouse microcirculation</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>3509</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24193509</pub-id></element-citation></ref><ref id="B19-molecules-26-00251"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>D.</given-names></name><name><surname>Tang</surname><given-names>S.</given-names></name><name><surname>Healy</surname><given-names>R.A.</given-names></name><name><surname>Imerman</surname><given-names>P.M.</given-names></name><name><surname>Schrunk</surname><given-names>D.E.</given-names></name><name><surname>Rumbeiha</surname><given-names>W.K.</given-names></name></person-group><article-title>A novel orellanine containing mushroom <italic>Cortinarius armillatus</italic></article-title><source>Toxicon</source><year>2016</year><volume>114</volume><fpage>65</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2016.02.010</pub-id><pub-id pub-id-type="pmid">26915341</pub-id></element-citation></ref><ref id="B20-molecules-26-00251"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buvall</surname><given-names>L.</given-names></name><name><surname>Hedman</surname><given-names>H.</given-names></name><name><surname>Khramova</surname><given-names>A.</given-names></name><name><surname>Najar</surname><given-names>D.</given-names></name><name><surname>Bergwall</surname><given-names>L.</given-names></name><name><surname>Ebefors</surname><given-names>K.</given-names></name><name><surname>Sihlbom</surname><given-names>C.</given-names></name><name><surname>Lundstam</surname><given-names>S.</given-names></name><name><surname>Herrmann</surname><given-names>A.</given-names></name><name><surname>Wallentin</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Orellanine specifically targets renal clear cell carcinoma</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>91085</fpage><lpage>91098</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.19555</pub-id><pub-id pub-id-type="pmid">29207627</pub-id></element-citation></ref><ref id="B21-molecules-26-00251"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.T.</given-names></name><name><surname>Winkler</surname><given-names>A.L.</given-names></name><name><surname>Schwan</surname><given-names>W.R.</given-names></name><name><surname>Volk</surname><given-names>T.J.</given-names></name><name><surname>Rott</surname><given-names>M.A.</given-names></name><name><surname>Monte</surname><given-names>A.</given-names></name></person-group><article-title>Antibacterial compounds from mushrooms I: A lanostane-type triterpene and prenylphenol derivatives from <italic>Jahnoporus hirtus</italic> and <italic>Albatrellus flettii</italic> and their activities against <italic>Bacillus cereus</italic> and <italic>Enterococcus faecalis</italic></article-title><source>Planta Med.</source><year>2010</year><volume>76</volume><fpage>182</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1055/s-0029-1186001</pub-id><pub-id pub-id-type="pmid">19644795</pub-id></element-citation></ref><ref id="B22-molecules-26-00251"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yaqoob</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>W.M.</given-names></name><name><surname>Liu</surname><given-names>V.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Mackedenski</surname><given-names>S.</given-names></name><name><surname>Tackaberry</surname><given-names>L.E.</given-names></name><name><surname>Massicotte</surname><given-names>H.B.</given-names></name><name><surname>Egger</surname><given-names>K.N.</given-names></name><name><surname>Reimer</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>C.H.</given-names></name></person-group><article-title>Grifolin, neogrifolin and confluentin from the terricolous polypore <italic>Albatrellus flettii</italic> suppress KRAS expression in human colon cancer cells</article-title><source>PLoS ONE</source><year>2020</year><volume>15</volume><elocation-id>e0231948</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0231948</pub-id><pub-id pub-id-type="pmid">32369483</pub-id></element-citation></ref><ref id="B23-molecules-26-00251"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deo</surname><given-names>G.S.</given-names></name><name><surname>Khatra</surname><given-names>J.</given-names></name><name><surname>Buttar</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>W.M.</given-names></name><name><surname>Tackaberry</surname><given-names>L.E.</given-names></name><name><surname>Massicotte</surname><given-names>H.B.</given-names></name><name><surname>Egger</surname><given-names>K.N.</given-names></name><name><surname>Reimer</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>C.H.</given-names></name></person-group><article-title>Antiproliferative, immuno-stimulatory, and anti-inflammatory activities of extracts derived from mushrooms collected in Haida Gwaii, British Columbia (Canada)</article-title><source>Int. J. Med. Mushrooms</source><year>2019</year><volume>21</volume><fpage>629</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1615/IntJMedMushrooms.2019031193</pub-id><pub-id pub-id-type="pmid">31679298</pub-id></element-citation></ref><ref id="B24-molecules-26-00251"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>A.</given-names></name><name><surname>Javed</surname><given-names>S.</given-names></name><name><surname>Barad</surname><given-names>A.</given-names></name><name><surname>Myhre</surname><given-names>V.</given-names></name><name><surname>Li</surname><given-names>W.M.</given-names></name><name><surname>Reimer</surname><given-names>K.</given-names></name><name><surname>Massicotte</surname><given-names>H.B.</given-names></name><name><surname>Tackaberry</surname><given-names>L.E.</given-names></name><name><surname>Payne</surname><given-names>G.W.</given-names></name><name><surname>Egger</surname><given-names>K.N.</given-names></name><etal/></person-group><article-title>Growth-inhibitory and immunomodulatory activities of wild mushrooms from North-Central British Columbia (Canada)</article-title><source>Int. J. Med. Mushrooms</source><year>2017</year><volume>19</volume><fpage>485</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.1615/IntJMedMushrooms.v19.i6.10</pub-id><pub-id pub-id-type="pmid">29199559</pub-id></element-citation></ref><ref id="B25-molecules-26-00251"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanikunaite</surname><given-names>R.</given-names></name><name><surname>Trappe</surname><given-names>J.M.</given-names></name><name><surname>Khan</surname><given-names>S.I.</given-names></name><name><surname>Ross</surname><given-names>S.A.</given-names></name></person-group><article-title>Evaluation of therapeutic activity of hypogeous ascomycetes and basidiomycetes from North America</article-title><source>Int. J. Med. Mushrooms</source><year>2007</year><volume>9</volume><fpage>7</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1615/IntJMedMushr.v9.i1.20</pub-id></element-citation></ref><ref id="B26-molecules-26-00251"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassan</surname><given-names>F.</given-names></name><name><surname>Ni</surname><given-names>S.</given-names></name><name><surname>Becker</surname><given-names>T.L.</given-names></name><name><surname>Kinstedt</surname><given-names>C.M.</given-names></name><name><surname>Abdul-Samad</surname><given-names>J.L.</given-names></name><name><surname>Actis</surname><given-names>L.A.</given-names></name><name><surname>Kennedy</surname><given-names>M.A.</given-names></name></person-group><article-title>Evaluation of the antibacterial activity of 75 mushrooms collected in the vicinity of Oxford, Ohio (USA)</article-title><source>Int. J. Med. Mushrooms</source><year>2019</year><volume>21</volume><fpage>131</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1615/IntJMedMushrooms.2018029710</pub-id><pub-id pub-id-type="pmid">30806220</pub-id></element-citation></ref><ref id="B27-molecules-26-00251"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>Y.H.</given-names></name><name><surname>Leonard</surname><given-names>J.</given-names></name></person-group><article-title>In vitro effects on proliferation, apoptosis and colony inhibition in ER-dependent and ER-independent human breast cancer cells by selected mushroom species</article-title><source>Oncol. Rep.</source><year>2006</year><volume>15</volume><fpage>417</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.3892/or.15.2.417</pub-id><?supplied-pmid 16391863?><pub-id pub-id-type="pmid">16391863</pub-id></element-citation></ref><ref id="B28-molecules-26-00251"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>K.</given-names></name><name><surname>Yang</surname><given-names>G.</given-names></name><name><surname>Xia</surname><given-names>C.</given-names></name><name><surname>Polston</surname><given-names>J.E.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Lin</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>L.J.</given-names></name><name><surname>Bruner</surname><given-names>S.D.</given-names></name><etal/></person-group><article-title>Cytotoxic protein from the mushroom <italic>Coprinus comatus</italic> possesses a unique mode for glycan binding and specificity</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2017</year><volume>114</volume><fpage>8980</fpage><lpage>8985</lpage><pub-id pub-id-type="doi">10.1073/pnas.1706894114</pub-id><?supplied-pmid 28784797?><pub-id pub-id-type="pmid">28784797</pub-id></element-citation></ref><ref id="B29-molecules-26-00251"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanikunaite</surname><given-names>R.</given-names></name><name><surname>Khan</surname><given-names>S.I.</given-names></name><name><surname>Trappe</surname><given-names>J.M.</given-names></name><name><surname>Ross</surname><given-names>S.A.</given-names></name></person-group><article-title>Cyclooxygenase-2 inhibitory and antioxidant compounds from the truffle <italic>Elaphomyces granulatus</italic></article-title><source>Phytother. Res.</source><year>2009</year><volume>23</volume><fpage>575</fpage><lpage>578</lpage><pub-id pub-id-type="doi">10.1002/ptr.2698</pub-id><?supplied-pmid 19067382?><pub-id pub-id-type="pmid">19067382</pub-id></element-citation></ref><ref id="B30-molecules-26-00251"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.T.</given-names></name><name><surname>Winkler</surname><given-names>A.L.</given-names></name><name><surname>Schwan</surname><given-names>W.R.</given-names></name><name><surname>Volk</surname><given-names>T.J.</given-names></name><name><surname>Rott</surname><given-names>M.</given-names></name><name><surname>Monte</surname><given-names>A.</given-names></name></person-group><article-title>Antibacterial compounds from mushrooms II: Lanostane triterpenoids and an ergostane steroid with activity against <italic>Bacillus cereus</italic> isolated from <italic>Fomitopsis pinicola</italic></article-title><source>Planta Med.</source><year>2010</year><volume>76</volume><fpage>464</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1055/s-0029-1186227</pub-id><?supplied-pmid 19847745?><pub-id pub-id-type="pmid">19847745</pub-id></element-citation></ref><ref id="B31-molecules-26-00251"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacheco-Sanchez</surname><given-names>M.</given-names></name><name><surname>Boutin</surname><given-names>Y.</given-names></name><name><surname>Angers</surname><given-names>P.</given-names></name><name><surname>Gosselin</surname><given-names>A.</given-names></name><name><surname>Tweddell</surname><given-names>R.J.</given-names></name></person-group><article-title>A bioactive (1&#x02192;3)-, (1&#x02192;4)-&#x003b2;-d-glucan from <italic>Collybia dryophila</italic> and other mushrooms</article-title><source>Mycologia</source><year>2006</year><volume>98</volume><fpage>180</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.3852/mycologia.98.2.180</pub-id><pub-id pub-id-type="pmid">16894963</pub-id></element-citation></ref><ref id="B32-molecules-26-00251"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacheco-S&#x000e1;nchez</surname><given-names>M.</given-names></name><name><surname>Boutin</surname><given-names>Y.</given-names></name><name><surname>Angers</surname><given-names>P.</given-names></name><name><surname>Gosselin</surname><given-names>A.</given-names></name><name><surname>Tweddell</surname><given-names>R.J.</given-names></name></person-group><article-title>Inhibitory effect of CDP, a polysaccharide extracted from the mushroom <italic>Collybia dryophila</italic>, on nitric oxide synthase expression and nitric oxide production in macrophages</article-title><source>Eur. J. Pharmacol.</source><year>2007</year><volume>555</volume><fpage>61</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2006.10.015</pub-id><pub-id pub-id-type="pmid">17125764</pub-id></element-citation></ref><ref id="B33-molecules-26-00251"><label>33.</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Shideler</surname><given-names>S.</given-names></name><name><surname>Reckseidler-Zenteno</surname><given-names>S.</given-names></name><name><surname>Treu</surname><given-names>R.</given-names></name><name><surname>Lewenza</surname><given-names>S.</given-names></name></person-group><article-title>Membrane damage-responsive biosensors for the discovery of antimicrobials from <italic>Lenzites betulina</italic> and <italic>Haploporus odorus</italic></article-title><source>Proceedings of the 2017 URSCA</source><conf-loc>Calgary, Alberta</conf-loc><conf-date>7&#x02013;8 April 2017</conf-date><volume>Volume 3</volume></element-citation></ref><ref id="B34-molecules-26-00251"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javed</surname><given-names>S.</given-names></name><name><surname>Mitchell</surname><given-names>K.</given-names></name><name><surname>Sidsworth</surname><given-names>D.</given-names></name><name><surname>Sellers</surname><given-names>S.L.</given-names></name><name><surname>Reutens-Hernandez</surname><given-names>J.</given-names></name><name><surname>Massicotte</surname><given-names>H.B.</given-names></name><name><surname>Egger</surname><given-names>K.N.</given-names></name><name><surname>Payne</surname><given-names>G.W.</given-names></name><name><surname>Lee</surname><given-names>C.H.</given-names></name></person-group><article-title><italic>Inonotus obliquus</italic> attenuates histamine-induced microvascular inflammation</article-title><source>PLoS ONE</source><year>2019</year><volume>14</volume><elocation-id>e0220776</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0220776</pub-id><?supplied-pmid 31437163?><pub-id pub-id-type="pmid">31437163</pub-id></element-citation></ref><ref id="B35-molecules-26-00251"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van</surname><given-names>Q.</given-names></name><name><surname>Nayak</surname><given-names>B.N.</given-names></name><name><surname>Reimer</surname><given-names>M.</given-names></name><name><surname>Jones</surname><given-names>P.J.H.</given-names></name><name><surname>Fulcher</surname><given-names>R.G.</given-names></name><name><surname>Rempel</surname><given-names>C.B.</given-names></name></person-group><article-title>Anti-inflammatory effect of <italic>Inonotus obliquus</italic>, <italic>Polygala senega</italic> L., and <italic>Viburnum trilobum</italic> in a cell screening assay</article-title><source>J. Ethnopharmacol.</source><year>2009</year><volume>125</volume><fpage>487</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2009.06.026</pub-id><pub-id pub-id-type="pmid">19577624</pub-id></element-citation></ref><ref id="B36-molecules-26-00251"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwan</surname><given-names>W.R.</given-names></name><name><surname>Dunek</surname><given-names>C.</given-names></name><name><surname>Gebhardt</surname><given-names>M.</given-names></name><name><surname>Engelbrecht</surname><given-names>K.</given-names></name><name><surname>Klett</surname><given-names>T.</given-names></name><name><surname>Monte</surname><given-names>A.</given-names></name><name><surname>Toce</surname><given-names>J.</given-names></name><name><surname>Rott</surname><given-names>M.</given-names></name><name><surname>Volk</surname><given-names>T.J.</given-names></name><name><surname>Lipuma</surname><given-names>J.L.</given-names></name><etal/></person-group><article-title>Screening a mushroom extract library for activity against <italic>Acinetobacter baumannii</italic> and <italic>Burkholderia cepacia</italic> and the identification of a compound with anti-Burkholderia activity</article-title><source>Annals Clin. Microbiol. Antimicrob.</source><year>2010</year><volume>9</volume><fpage>4</fpage><pub-id pub-id-type="doi">10.1186/1476-0711-9-4</pub-id><?supplied-pmid 20092635?><pub-id pub-id-type="pmid">20092635</pub-id></element-citation></ref><ref id="B37-molecules-26-00251"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barad</surname><given-names>A.</given-names></name><name><surname>Mackedenski</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>W.M.</given-names></name><name><surname>Li</surname><given-names>X.J.</given-names></name><name><surname>Lim</surname><given-names>B.C.C.</given-names></name><name><surname>Rashid</surname><given-names>F.</given-names></name><name><surname>Tackaberry</surname><given-names>L.E.</given-names></name><name><surname>Massicotte</surname><given-names>H.B.</given-names></name><name><surname>Egger</surname><given-names>K.N.</given-names></name><name><surname>Reimer</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Anti-proliferative activity of a purified polysaccharide isolated from the basidiomycete fungus <italic>Paxillus involutus</italic></article-title><source>Carbohydr. Polym.</source><year>2018</year><volume>181</volume><fpage>923</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2017.11.058</pub-id><pub-id pub-id-type="pmid">29254055</pub-id></element-citation></ref><ref id="B38-molecules-26-00251"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pineda-Alegr&#x000ed;a</surname><given-names>J.A.</given-names></name><name><surname>S&#x000e1;nchez-V&#x000e1;zquez</surname><given-names>J.E.</given-names></name><name><surname>Gonz&#x000e1;lez-Cortazar</surname><given-names>M.</given-names></name><name><surname>Zamilpa</surname><given-names>A.</given-names></name><name><surname>L&#x000f3;pez-Arellano</surname><given-names>M.E.</given-names></name><name><surname>Cuevas-Padilla</surname><given-names>E.J.</given-names></name><name><surname>Mendoza-de-Gives</surname><given-names>P.</given-names></name><name><surname>Aguilar-Marcelino</surname><given-names>L.</given-names></name></person-group><article-title>The edible mushroom <italic>Pleurotus djamor</italic> produces metabolites with lethal activity against the parasitic nematode <italic>Haemonchus contortus</italic></article-title><source>J. Med. Food</source><year>2017</year><volume>20</volume><fpage>1184</fpage><lpage>1192</lpage><pub-id pub-id-type="doi">10.1089/jmf.2017.0031</pub-id><pub-id pub-id-type="pmid">28767008</pub-id></element-citation></ref><ref id="B39-molecules-26-00251"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adebayo</surname><given-names>E.A.</given-names></name><name><surname>Mart&#x000ed;nez-Carrera</surname><given-names>D.</given-names></name><name><surname>Morales</surname><given-names>P.</given-names></name><name><surname>Sobal</surname><given-names>M.</given-names></name><name><surname>Escudero</surname><given-names>H.</given-names></name><name><surname>Meneses</surname><given-names>M.E.</given-names></name><name><surname>Avila-Nava</surname><given-names>A.</given-names></name><name><surname>Castillo</surname><given-names>I.</given-names></name><name><surname>Bonilla</surname><given-names>M.</given-names></name></person-group><article-title>Comparative study of antioxidant and antibacterial properties of the edible mushrooms <italic>Pleurotus levis</italic>, <italic>P. ostreatus</italic>, <italic>P. pulmonarius</italic> and <italic>P. tuber-regium</italic></article-title><source>Int. J. Food Sci.</source><year>2018</year><volume>53</volume><fpage>1316</fpage><lpage>1330</lpage><pub-id pub-id-type="doi">10.1111/ijfs.13712</pub-id></element-citation></ref><ref id="B40-molecules-26-00251"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B.B.</given-names></name><name><surname>Cheung</surname><given-names>P.C.</given-names></name></person-group><article-title>Use of stimulatory agents to enhance the production of bioactive exopolysaccharide from <italic>Pleurotus tuber-regium</italic> by submerged fermentation</article-title><source>J. Agric. Food Chem.</source><year>2011</year><volume>59</volume><fpage>1210</fpage><lpage>1216</lpage><pub-id pub-id-type="doi">10.1021/jf104425w</pub-id><pub-id pub-id-type="pmid">21280626</pub-id></element-citation></ref><ref id="B41-molecules-26-00251"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.T.</given-names></name><name><surname>Schwan</surname><given-names>W.R.</given-names></name><name><surname>Volk</surname><given-names>T.J.</given-names></name><name><surname>Rott</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Huang</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zitomer</surname><given-names>N.C.</given-names></name><name><surname>Sleger</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Antibacterial spirobisnaphthalenes from the North American cup fungus <italic>Urnula craterium</italic></article-title><source>J. Nat. Prod.</source><year>2012</year><volume>75</volume><fpage>1534</fpage><lpage>1538</lpage><pub-id pub-id-type="doi">10.1021/np300221a</pub-id><pub-id pub-id-type="pmid">22934636</pub-id></element-citation></ref><ref id="B42-molecules-26-00251"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wasser</surname><given-names>S.P.</given-names></name></person-group><article-title>Medicinal mushrooms in human clinical studies. Part I. Anticancer, oncoimmunological, and immunomodulatory activities: A review</article-title><source>Int. J. Med. Mushrooms</source><year>2017</year><volume>19</volume><fpage>279</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1615/IntJMedMushrooms.v19.i4.10</pub-id><pub-id pub-id-type="pmid">28605319</pub-id></element-citation></ref><ref id="B43-molecules-26-00251"><label>43.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Council of Canadian Academies</collab></person-group><source>When Antibiotics Fail: The Expert Panel on the Potential Socio-Economic Impacts of Antimicrobial Resistance in Canada</source><publisher-name>Council of Canadian Academies</publisher-name><publisher-loc>Ottawa, ON, USA</publisher-loc><year>2019</year></element-citation></ref><ref id="B44-molecules-26-00251"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strachan</surname><given-names>C.R.</given-names></name><name><surname>Davies</surname><given-names>J.</given-names></name></person-group><article-title>The whys and wherefores of antibiotic resistance</article-title><source>Cold Spring Harb. Perspect. Med.</source><year>2017</year><volume>7</volume><fpage>a025171</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a025171</pub-id><pub-id pub-id-type="pmid">27793964</pub-id></element-citation></ref><ref id="B45-molecules-26-00251"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gould</surname><given-names>I.M.</given-names></name><name><surname>Gunasekara</surname><given-names>C.</given-names></name><name><surname>Khan</surname><given-names>A.</given-names></name></person-group><article-title>Antibacterials in the pipeline and perspectives for the near future</article-title><source>Curr. Opin. Pharmacol.</source><year>2019</year><volume>48</volume><fpage>69</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.coph.2019.05.001</pub-id><?supplied-pmid 31200170?><pub-id pub-id-type="pmid">31200170</pub-id></element-citation></ref><ref id="B46-molecules-26-00251"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alves</surname><given-names>M.J.</given-names></name><name><surname>Ferreira</surname><given-names>I.C.</given-names></name><name><surname>Dias</surname><given-names>J.F.</given-names></name><name><surname>Teixeira</surname><given-names>V.</given-names></name><name><surname>Martins</surname><given-names>A.</given-names></name><name><surname>Pintado</surname><given-names>M.</given-names></name></person-group><article-title>A review on antimicrobial activity of mushroom (Basidiomycetes) extracts and isolated compounds</article-title><source>Planta Med.</source><year>2012</year><volume>78</volume><fpage>1707</fpage><lpage>1718</lpage><pub-id pub-id-type="doi">10.1055/s-0032-1315370</pub-id><?supplied-pmid 23023950?><pub-id pub-id-type="pmid">23023950</pub-id></element-citation></ref><ref id="B47-molecules-26-00251"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>N.K.</given-names></name><name><surname>Fukushi</surname><given-names>Y.</given-names></name><name><surname>Yamaji</surname><given-names>K.</given-names></name><name><surname>Tahara</surname><given-names>S.</given-names></name><name><surname>Takahashi</surname><given-names>K.</given-names></name></person-group><article-title>Antimicrobial cuparene-type sesquiterpenes, enokipodins C and D, from a mycelial culture of flammulina v elutipes</article-title><source>J. Nat. Prod.</source><year>2001</year><volume>64</volume><fpage>932</fpage><lpage>934</lpage><pub-id pub-id-type="doi">10.1021/np000593r</pub-id><?supplied-pmid 11473426?><pub-id pub-id-type="pmid">11473426</pub-id></element-citation></ref><ref id="B48-molecules-26-00251"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beattie</surname><given-names>K.D.</given-names></name><name><surname>Rouf</surname><given-names>R.</given-names></name><name><surname>Gander</surname><given-names>L.</given-names></name><name><surname>May</surname><given-names>T.W.</given-names></name><name><surname>Ratkowsky</surname><given-names>D.</given-names></name><name><surname>Donner</surname><given-names>C.D.</given-names></name><name><surname>Gill</surname><given-names>M.</given-names></name><name><surname>Tiralongo</surname><given-names>E.</given-names></name></person-group><article-title>Antibacterial metabolites from Australian macrofungi from the genus Cortinarius</article-title><source>Phytochemistry</source><year>2010</year><volume>71</volume><fpage>948</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2010.03.016</pub-id><?supplied-pmid 20392467?><pub-id pub-id-type="pmid">20392467</pub-id></element-citation></ref><ref id="B49-molecules-26-00251"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bender</surname><given-names>S.</given-names></name><name><surname>Dumitrache-Anghel</surname><given-names>C.N.</given-names></name><name><surname>Backhaus</surname><given-names>J.</given-names></name><name><surname>Christie</surname><given-names>G.</given-names></name><name><surname>Cross</surname><given-names>R.F.</given-names></name><name><surname>Lonergan</surname><given-names>G.T.</given-names></name><name><surname>Baker</surname><given-names>W.L.</given-names></name></person-group><article-title>A case for caution in assessing the antibiotic activity of extracts of culinary-medicinal Shiitake mushroom [Lentinus edodes (Berk.) Singer] (Agaricomycetideae)</article-title><source>Int. J. Med. Mushrooms</source><year>2003</year><volume>5</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1615/IntJMedMushr.v5.i1.40</pub-id></element-citation></ref><ref id="B50-molecules-26-00251"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Centko</surname><given-names>R.M.</given-names></name><name><surname>Ramon-Garcia</surname><given-names>S.</given-names></name><name><surname>Taylor</surname><given-names>T.</given-names></name><name><surname>Patrick</surname><given-names>B.O.</given-names></name><name><surname>Thompson</surname><given-names>C.J.</given-names></name><name><surname>Miao</surname><given-names>V.P.</given-names></name><name><surname>Andersen</surname><given-names>R.J.</given-names></name></person-group><article-title>Ramariolides A-D, antimycobacterial butenolides isolated from the mushroom <italic>Ramaria cystidiophora</italic></article-title><source>J. Nat. Prod.</source><year>2012</year><volume>75</volume><fpage>2178</fpage><lpage>2182</lpage><pub-id pub-id-type="doi">10.1021/np3006277</pub-id><pub-id pub-id-type="pmid">23205944</pub-id></element-citation></ref><ref id="B51-molecules-26-00251"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamets</surname><given-names>P.E.</given-names></name><name><surname>Naeger</surname><given-names>N.L.</given-names></name><name><surname>Evans</surname><given-names>J.D.</given-names></name><name><surname>Han</surname><given-names>J.O.</given-names></name><name><surname>Hopkins</surname><given-names>B.K.</given-names></name><name><surname>Lopez</surname><given-names>D.</given-names></name><name><surname>Moershel</surname><given-names>H.M.</given-names></name><name><surname>Naily</surname><given-names>R.</given-names></name><name><surname>Sumerlin</surname><given-names>D.</given-names></name><name><surname>Taylor</surname><given-names>A.W.</given-names></name><etal/></person-group><article-title>Extracts from polypore mushroom mycelia reduce viruses in honey bees</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>13936</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-32194-8</pub-id><pub-id pub-id-type="pmid">30287824</pub-id></element-citation></ref><ref id="B52-molecules-26-00251"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maness</surname><given-names>L.</given-names></name><name><surname>Sneed</surname><given-names>N.</given-names></name><name><surname>Hardy</surname><given-names>B.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Ahmedna</surname><given-names>M.</given-names></name><name><surname>Goktepe</surname><given-names>I.</given-names></name></person-group><article-title>Anti-proliferative effect of <italic>Pleurotus tuberregium</italic> against colon and cervical cancer cells</article-title><source>J. Med. Plants Res.</source><year>2011</year><volume>5</volume><fpage>6650</fpage><lpage>6655</lpage><pub-id pub-id-type="doi">10.5897/JMPR11.457</pub-id></element-citation></ref><ref id="B53-molecules-26-00251"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roda</surname><given-names>E.</given-names></name><name><surname>De Luca</surname><given-names>F.</given-names></name><name><surname>Di Iorio</surname><given-names>C.</given-names></name><name><surname>Ratto</surname><given-names>D.</given-names></name><name><surname>Siciliani</surname><given-names>S.</given-names></name><name><surname>Ferrari</surname><given-names>B.</given-names></name><name><surname>Cobelli</surname><given-names>F.</given-names></name><name><surname>Borsci</surname><given-names>G.</given-names></name><name><surname>Priori</surname><given-names>E.C.</given-names></name><name><surname>Chinosi</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Novel medicinal mushroom blend as a promising supplement in integrative oncology: A multi-tiered study using 4T1 triple-negative mouse breast cancer model</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>3479</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21103479</pub-id></element-citation></ref><ref id="B54-molecules-26-00251"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S.N.</given-names></name><name><surname>Chang</surname><given-names>C.S.</given-names></name><name><surname>Hung</surname><given-names>M.H.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Tai</surname><given-names>C.J.</given-names></name><name><surname>Lu</surname><given-names>C.L.</given-names></name></person-group><article-title>The effect of mushroom beta-glucans from solid culture of <italic>Ganoderma lucidum</italic> on inhibition of the primary tumor metastasis</article-title><source>Evid. Based Complementary Altern. Med.</source><year>2014</year><volume>2014</volume><fpage>1</fpage><lpage>7</lpage></element-citation></ref><ref id="B55-molecules-26-00251"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masuda</surname><given-names>Y.</given-names></name><name><surname>Inoue</surname><given-names>M.</given-names></name><name><surname>Miyata</surname><given-names>A.</given-names></name><name><surname>Mizuno</surname><given-names>S.</given-names></name><name><surname>Nanba</surname><given-names>H.</given-names></name></person-group><article-title>Maitake &#x003b2;-glucan enhances therapeutic effect and reduces myelosupression and nephrotoxicity of cisplatin in mice</article-title><source>Int. Immunopharmacol.</source><year>2009</year><volume>9</volume><fpage>620</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2009.02.005</pub-id><?supplied-pmid 19249389?><pub-id pub-id-type="pmid">19249389</pub-id></element-citation></ref><ref id="B56-molecules-26-00251"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>H.T.</given-names></name><name><surname>Lu</surname><given-names>F.H.</given-names></name><name><surname>Su</surname><given-names>Y.C.</given-names></name><name><surname>Ou</surname><given-names>H.Y.</given-names></name><name><surname>Hung</surname><given-names>H.C.</given-names></name><name><surname>Wu</surname><given-names>J.S.</given-names></name><name><surname>Yang</surname><given-names>Y.C.</given-names></name><name><surname>Chang</surname><given-names>C.J.</given-names></name></person-group><article-title>In vivo and in vitro anti-tumor effects of fungal extracts</article-title><source>Molecules</source><year>2014</year><volume>19</volume><fpage>2546</fpage><lpage>2556</lpage><pub-id pub-id-type="doi">10.3390/molecules19022546</pub-id><?supplied-pmid 24566320?><pub-id pub-id-type="pmid">24566320</pub-id></element-citation></ref><ref id="B57-molecules-26-00251"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Yu</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Xu</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>He</surname><given-names>S.</given-names></name><name><surname>Cao</surname><given-names>S.</given-names></name><name><surname>Tan</surname><given-names>G.</given-names></name></person-group><article-title>Anticancer potential of <italic>Hericium erinaceus</italic> extracts against human gastrointestinal cancers</article-title><source>J. Ethnopharmacol.</source><year>2014</year><volume>153</volume><fpage>521</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2014.03.003</pub-id><?supplied-pmid 24631140?><pub-id pub-id-type="pmid">24631140</pub-id></element-citation></ref><ref id="B58-molecules-26-00251"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S.P.</given-names></name><name><surname>Nam</surname><given-names>S.H.</given-names></name><name><surname>Friedman</surname><given-names>M.</given-names></name></person-group><article-title><italic>Hericium erinaceus</italic> (Lion&#x02019;s Mane) mushroom extracts inhibit metastasis of cancer cells to the lung in CT-26 colon cancer-transplanted mice</article-title><source>J. Agric. Food Chem.</source><year>2013</year><volume>61</volume><fpage>4898</fpage><lpage>4904</lpage><pub-id pub-id-type="doi">10.1021/jf400916c</pub-id><pub-id pub-id-type="pmid">23668749</pub-id></element-citation></ref><ref id="B59-molecules-26-00251"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>C.C.</given-names></name><name><surname>Huang</surname><given-names>W.S.</given-names></name><name><surname>Lee</surname><given-names>K.F.</given-names></name><name><surname>Lee</surname><given-names>K.C.</given-names></name><name><surname>Hsieh</surname><given-names>M.C.</given-names></name><name><surname>Huang</surname><given-names>C.Y.</given-names></name><name><surname>Lee</surname><given-names>L.Y.</given-names></name><name><surname>Lee</surname><given-names>B.O.</given-names></name><name><surname>Teng</surname><given-names>C.C.</given-names></name><name><surname>Shen</surname><given-names>C.H.</given-names></name><etal/></person-group><article-title>Inhibitory effect of Erinacines A on the growth of DLD-1 colorectal cancer cells is induced by generation of reactive oxygen species and activation of p70S6K and p21</article-title><source>J. Funct. Foods</source><year>2016</year><volume>21</volume><fpage>474</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1016/j.jff.2015.12.031</pub-id></element-citation></ref><ref id="B60-molecules-26-00251"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diling</surname><given-names>C.</given-names></name><name><surname>Chaoqun</surname><given-names>Z.</given-names></name><name><surname>Jian</surname><given-names>Y.</given-names></name><name><surname>Jian</surname><given-names>L.</given-names></name><name><surname>Jiyan</surname><given-names>S.</given-names></name><name><surname>Yishen</surname><given-names>X.</given-names></name><name><surname>Guoxiao</surname><given-names>L.</given-names></name></person-group><article-title>Immunomodulatory activities of a fungal protein extracted from <italic>Hericium erinaceus</italic> through regulating the gut microbiota</article-title><source>Front. Immunol.</source><year>2017</year><volume>8</volume><fpage>666</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2017.00666</pub-id><pub-id pub-id-type="pmid">28713364</pub-id></element-citation></ref><ref id="B61-molecules-26-00251"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.G.</given-names></name><name><surname>Ji</surname><given-names>D.F.</given-names></name><name><surname>Zhong</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>J.X.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Hu</surname><given-names>G.Y.</given-names></name></person-group><article-title>Anti-tumor effects of proteoglycan from <italic>Phellinus linteus</italic> by immunomodulating and inhibiting Reg IV/EGFR/Akt signaling pathway in colorectal carcinoma</article-title><source>Int. J. Biol. Macromol.</source><year>2011</year><volume>48</volume><fpage>511</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2011.01.014</pub-id><pub-id pub-id-type="pmid">21262260</pub-id></element-citation></ref><ref id="B62-molecules-26-00251"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Youn</surname><given-names>M.J.</given-names></name><name><surname>Kim</surname><given-names>J.K.</given-names></name><name><surname>Park</surname><given-names>S.Y.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Park</surname><given-names>C.</given-names></name><name><surname>Kim</surname><given-names>E.S.</given-names></name><name><surname>Park</surname><given-names>K.I.</given-names></name><name><surname>So</surname><given-names>H.S.</given-names></name><name><surname>Park</surname><given-names>R.</given-names></name></person-group><article-title>Potential anticancer properties of the water extract of <italic>Inonotus obliquus</italic> by induction of apoptosis in melanoma B16-F10 cells</article-title><source>J. Ethnopharmacol.</source><year>2009</year><volume>121</volume><fpage>221</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2008.10.016</pub-id><pub-id pub-id-type="pmid">19041933</pub-id></element-citation></ref><ref id="B63-molecules-26-00251"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>M.J.</given-names></name><name><surname>Chung</surname><given-names>C.K.</given-names></name><name><surname>Jeong</surname><given-names>Y.</given-names></name><name><surname>Ham</surname><given-names>S.S.</given-names></name></person-group><article-title>Anticancer activity of subfractions containing pure compounds of Chaga mushroom (<italic>Inonotus obliquus</italic>) extract in human cancer cells and in Balbc/c mice bearing Sarcoma-180 cells</article-title><source>Nutr. Res. Pract.</source><year>2010</year><volume>4</volume><fpage>177</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.4162/nrp.2010.4.3.177</pub-id><pub-id pub-id-type="pmid">20607061</pub-id></element-citation></ref><ref id="B64-molecules-26-00251"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakata</surname><given-names>T.</given-names></name><name><surname>Yamada</surname><given-names>T.</given-names></name><name><surname>Taji</surname><given-names>S.</given-names></name><name><surname>Ohishi</surname><given-names>H.</given-names></name><name><surname>Wada</surname><given-names>S.</given-names></name><name><surname>Tokuda</surname><given-names>H.</given-names></name><name><surname>Sakuma</surname><given-names>K.</given-names></name><name><surname>Tanaka</surname><given-names>R.</given-names></name></person-group><article-title>Structure determination of inonotsuoxides A and B and in vivo anti-tumor promoting activity of inotodiol from the sclerotia of <italic>Inonotus obliquus</italic></article-title><source>Bioorg. Med. Chem.</source><year>2007</year><volume>15</volume><fpage>257</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2006.09.064</pub-id><pub-id pub-id-type="pmid">17049251</pub-id></element-citation></ref><ref id="B65-molecules-26-00251"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nomura</surname><given-names>M.</given-names></name><name><surname>Takahashi</surname><given-names>T.</given-names></name><name><surname>Uesugi</surname><given-names>A.</given-names></name><name><surname>Tanaka</surname><given-names>R.</given-names></name><name><surname>Kobayashi</surname><given-names>S.</given-names></name></person-group><article-title>Inotodiol, a lanostane triterpenoid, from <italic>Inonotus obliquus inhibits</italic> cell proliferation through caspase-3-dependent apoptosis</article-title><source>Anticancer Res.</source><year>2008</year><volume>28</volume><fpage>2691</fpage><lpage>2696</lpage><?supplied-pmid 19035296?><pub-id pub-id-type="pmid">19035296</pub-id></element-citation></ref><ref id="B66-molecules-26-00251"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awadasseid</surname><given-names>A.</given-names></name><name><surname>Hou</surname><given-names>J.</given-names></name><name><surname>Gamallat</surname><given-names>Y.</given-names></name><name><surname>Xueqi</surname><given-names>S.</given-names></name><name><surname>Eugene</surname><given-names>K.D.</given-names></name><name><surname>Musa Hago</surname><given-names>A.</given-names></name><name><surname>Bamba</surname><given-names>D.</given-names></name><name><surname>Meyiah</surname><given-names>A.</given-names></name><name><surname>Gift</surname><given-names>C.</given-names></name><name><surname>Xin</surname><given-names>Y.</given-names></name></person-group><article-title>Purification, characterization and antitumor activity of a novel glucan from the fruiting bodies of <italic>Coriolus versicolor</italic></article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><elocation-id>e0171270</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0171270</pub-id><?supplied-pmid 28178285?><pub-id pub-id-type="pmid">28178285</pub-id></element-citation></ref><ref id="B67-molecules-26-00251"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Dai</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Ye</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>S.</given-names></name></person-group><article-title>A randomized, placebo-controlled, multicenter study of <italic>Ganoderma lucidum</italic> (W. Curt.: Fr.) Lloyd (Aphyllophoromycetideae) polysaccharides (Ganopoly<sup>&#x000ae;</sup>) in patients with advanced lung cancer</article-title><source>Int. J. Med. Mushrooms</source><year>2003</year><volume>5</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1615/InterJMedicMush.v5.i4.40</pub-id></element-citation></ref><ref id="B68-molecules-26-00251"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>M.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>W.</given-names></name><name><surname>Dai</surname><given-names>X.</given-names></name><name><surname>Gao</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Ye</surname><given-names>J.</given-names></name><name><surname>Chan</surname><given-names>E.</given-names></name><name><surname>Zhou</surname><given-names>S.</given-names></name></person-group><article-title>Immune responses to water-soluble Ling Zhi mushroom <italic>Ganoderma lucidum</italic> (W. Curt.: Fr.) P. Karst. polysaccharides in patients with advanced colorectal cancer</article-title><source>Int. J. Med. Mushrooms</source><year>2005</year><volume>7</volume><fpage>525</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1615/IntJMedMushr.v7.i4.20</pub-id></element-citation></ref><ref id="B69-molecules-26-00251"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>G.</given-names></name><name><surname>Smith-Jones</surname><given-names>H.L.</given-names></name><name><surname>Seidman</surname><given-names>A.D.</given-names></name><name><surname>Fornier</surname><given-names>M.</given-names></name><name><surname>D&#x02019;Andrea</surname><given-names>G.</given-names></name><name><surname>Wesa</surname><given-names>K.</given-names></name><name><surname>Cunningham-Rundles</surname><given-names>S.</given-names></name><name><surname>Yeung</surname><given-names>K.S.</given-names></name><name><surname>Vickers</surname><given-names>A.</given-names></name><name><surname>Cassileth</surname><given-names>B.R.</given-names></name></person-group><article-title>A phase I/II trial of a polysaccharide extract from <italic>Grifola frondosa</italic> (Maitake mushroom) in breast cancer patients</article-title><source>J. Clin. Oncol.</source><year>2008</year><volume>26</volume><fpage>3024</fpage><pub-id pub-id-type="doi">10.1200/jco.2008.26.15_suppl.3024</pub-id></element-citation></ref><ref id="B70-molecules-26-00251"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Xie</surname><given-names>X.</given-names></name><name><surname>Holman</surname><given-names>C.D.A.J.</given-names></name></person-group><article-title>Dietary intakes of mushrooms and green tea combine to reduce the risk of breast cancer in Chinese women</article-title><source>Int. J. Cancer</source><year>2009</year><volume>124</volume><fpage>1404</fpage><lpage>1408</lpage><pub-id pub-id-type="doi">10.1002/ijc.24047</pub-id><pub-id pub-id-type="pmid">19048616</pub-id></element-citation></ref><ref id="B71-molecules-26-00251"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hara</surname><given-names>M.</given-names></name><name><surname>Hanaoka</surname><given-names>T.</given-names></name><name><surname>Kobayashi</surname><given-names>M.</given-names></name><name><surname>Otani</surname><given-names>T.</given-names></name><name><surname>Adachi</surname><given-names>H.Y.</given-names></name><name><surname>Montani</surname><given-names>A.</given-names></name><name><surname>Natsukawa</surname><given-names>S.</given-names></name><name><surname>Shaura</surname><given-names>K.</given-names></name><name><surname>Koizumi</surname><given-names>Y.</given-names></name><name><surname>Kasuga</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Cruciferous vegetables, mushrooms, and gastrointestinal cancer risks in a multicenter, hospital-based case-control study in Japan</article-title><source>Nutr. Cancer</source><year>2003</year><volume>46</volume><fpage>138</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1207/S15327914NC4602_06</pub-id><pub-id pub-id-type="pmid">14690789</pub-id></element-citation></ref><ref id="B72-molecules-26-00251"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hazama</surname><given-names>S.</given-names></name><name><surname>Watanabe</surname><given-names>S.</given-names></name><name><surname>Ohashi</surname><given-names>M.</given-names></name><name><surname>Yagi</surname><given-names>M.</given-names></name><name><surname>Suzuki</surname><given-names>M.</given-names></name><name><surname>Matsuda</surname><given-names>K.</given-names></name><name><surname>Yamamoto</surname><given-names>T.</given-names></name><name><surname>Suga</surname><given-names>Y.</given-names></name><name><surname>Suga</surname><given-names>T.</given-names></name><name><surname>Nakazawa</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Efficacy of orally administered superfine dispersed lentinan (&#x003b2;-1, 3-glucan) for the treatment of advanced colorectal cancer</article-title><source>Anticancer Res.</source><year>2009</year><volume>29</volume><fpage>2611</fpage><lpage>2617</lpage><pub-id pub-id-type="pmid">19596936</pub-id></element-citation></ref><ref id="B73-molecules-26-00251"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Dong</surname><given-names>P.</given-names></name><name><surname>Lu</surname><given-names>X.</given-names></name></person-group><article-title>Anti-inflammatory and anticancer activities of extracts and compounds from the mushroom <italic>Inonotus obliquus</italic></article-title><source>Food Chem.</source><year>2013</year><volume>139</volume><fpage>503</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2013.01.030</pub-id><pub-id pub-id-type="pmid">23561137</pub-id></element-citation></ref><ref id="B74-molecules-26-00251"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>B.</given-names></name><name><surname>Zhu</surname><given-names>F.</given-names></name><name><surname>Xu</surname><given-names>B.</given-names></name></person-group><article-title>An insight into the anti-inflammatory properties of edible and medicinal mushrooms</article-title><source>J. Func. Foods</source><year>2018</year><volume>47</volume><fpage>334</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1016/j.jff.2018.06.003</pub-id></element-citation></ref><ref id="B75-molecules-26-00251"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ooi</surname><given-names>V.E.</given-names></name><name><surname>Liu</surname><given-names>F.</given-names></name></person-group><article-title>Immunomodulation and anti-cancer activity of polysaccharide-protein complexes</article-title><source>Curr. Med. Chem.</source><year>2000</year><volume>7</volume><fpage>715</fpage><lpage>729</lpage><pub-id pub-id-type="doi">10.2174/0929867003374705</pub-id><?supplied-pmid 10702635?><pub-id pub-id-type="pmid">10702635</pub-id></element-citation></ref><ref id="B76-molecules-26-00251"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enshasy</surname><given-names>H.A.E.</given-names></name><name><surname>Hatti-Kaul</surname><given-names>R.</given-names></name></person-group><article-title>Mushroom immunomodulators: Unique molecules with unlimited applications</article-title><source>Trends Biotech.</source><year>2014</year><volume>31</volume><fpage>668</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1016/j.tibtech.2013.09.003</pub-id></element-citation></ref><ref id="B77-molecules-26-00251"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giavasis</surname><given-names>I.</given-names></name></person-group><article-title>Bioactive fungal polysaccharides as potential functional ingredients in food and nutraceuticals</article-title><source>Curr. Opin. Biotech.</source><year>2014</year><volume>26</volume><fpage>162</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1016/j.copbio.2014.01.010</pub-id><?supplied-pmid 24518400?><pub-id pub-id-type="pmid">24518400</pub-id></element-citation></ref><ref id="B78-molecules-26-00251"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Persin</surname><given-names>Z.</given-names></name><name><surname>Stana-Kleinschek</surname><given-names>K.</given-names></name><name><surname>Foster</surname><given-names>T.J.</given-names></name><name><surname>van Dam</surname><given-names>J.E.G.</given-names></name><name><surname>Boeriu</surname><given-names>C.G.</given-names></name><name><surname>Navard</surname><given-names>P.</given-names></name></person-group><article-title>Challenges and opportunities in polysaccharides research and technology: The EPNOE views for the next decade in the areas of materials, food and health care</article-title><source>Carbohydr. Polym.</source><year>2011</year><volume>84</volume><fpage>22</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2010.11.044</pub-id></element-citation></ref><ref id="B79-molecules-26-00251"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Z.B.</given-names></name><name><surname>Zhang</surname><given-names>H.N.</given-names></name></person-group><article-title>Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms</article-title><source>Acta Pharmacol. Sinica</source><year>2004</year><volume>25</volume><fpage>1387</fpage><lpage>1395</lpage></element-citation></ref><ref id="B80-molecules-26-00251"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakopovic</surname><given-names>B.</given-names></name><name><surname>Or&#x00161;oli&#x00107;</surname><given-names>N.</given-names></name><name><surname>Kraljevi&#x00107; Paveli&#x00107;</surname><given-names>S.</given-names></name></person-group><article-title>Antitumor, Immunomodulatory and Antiangiogenic Efficacy of Medicinal Mushroom Extract Mixtures in Advanced Colorectal Cancer Animal Model</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>5005</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25215005</pub-id></element-citation></ref><ref id="B81-molecules-26-00251"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ullah</surname><given-names>M.I.</given-names></name><name><surname>Akhtar</surname><given-names>M.</given-names></name><name><surname>Awais</surname><given-names>M.M.</given-names></name><name><surname>Anwar</surname><given-names>M.I.</given-names></name><name><surname>Khaliq</surname><given-names>K.</given-names></name></person-group><article-title>Evaluation of immunostimulatory and immunotherapeutic effects of tropical mushroom (Lentinus edodes) against eimeriasis in chicken</article-title><source>Trop. Anim. Health Prod.</source><year>2018</year><volume>50</volume><fpage>97</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1007/s11250-017-1407-4</pub-id><pub-id pub-id-type="pmid">28942500</pub-id></element-citation></ref><ref id="B82-molecules-26-00251"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>G.</given-names></name><name><surname>Lin</surname><given-names>H.</given-names></name><name><surname>Seidman</surname><given-names>A.</given-names></name><name><surname>Fornier</surname><given-names>M.</given-names></name><name><surname>D&#x02019;Andrea</surname><given-names>G.</given-names></name><name><surname>Wesa</surname><given-names>K.</given-names></name><name><surname>Yeung</surname><given-names>S.</given-names></name><name><surname>Cunningham-Rundles</surname><given-names>S.</given-names></name><name><surname>Vickers</surname><given-names>A.J.</given-names></name><name><surname>Cassileth</surname><given-names>B.</given-names></name></person-group><article-title>A phase I/II trial of a polysaccharide extract from <italic>Grifola frondosa</italic> (Maitake mushroom) in breast cancer patients: Immunological effects</article-title><source>J. Cancer Res. Clin. Oncol.</source><year>2009</year><volume>135</volume><fpage>1215</fpage><lpage>1221</lpage><pub-id pub-id-type="doi">10.1007/s00432-009-0562-z</pub-id><pub-id pub-id-type="pmid">19253021</pub-id></element-citation></ref><ref id="B83-molecules-26-00251"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yurkiv</surname><given-names>B.</given-names></name><name><surname>Wasser</surname><given-names>S.P.</given-names></name><name><surname>Nevo</surname><given-names>E.D.</given-names></name><name><surname>Sybirna</surname><given-names>N.O.</given-names></name></person-group><article-title>Antioxidant effects of medicinal mushrooms Agaricus brasiliensis and Ganoderma lucidum (higher Basidiomycetes): Evidence from animal studies</article-title><source>Int. J. Med. Mushrooms</source><year>2015</year><volume>17</volume><fpage>943</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1615/IntJMedMushrooms.v17.i10.40</pub-id><pub-id pub-id-type="pmid">26756186</pub-id></element-citation></ref><ref id="B84-molecules-26-00251"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vitak</surname><given-names>T.Y.</given-names></name><name><surname>Wasser</surname><given-names>S.P.</given-names></name><name><surname>Nevo</surname><given-names>E.D.</given-names></name><name><surname>Sybirna</surname><given-names>N.O.</given-names></name></person-group><article-title>Enzymatic system of antioxidant protection of erythrocytes in diabetic rats treated with medicinal mushrooms Agaricus brasiliensis and Ganoderma lucidum (Agaricomycetes)</article-title><source>Int. J. Med. Mushrooms</source><year>2017</year><volume>19</volume><fpage>697</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.1615/IntJMedMushrooms.2017021305</pub-id><pub-id pub-id-type="pmid">29199569</pub-id></element-citation></ref><ref id="B85-molecules-26-00251"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeh</surname><given-names>M.Y.</given-names></name><name><surname>Ko</surname><given-names>W.C.</given-names></name><name><surname>Lin</surname><given-names>L.Y.</given-names></name></person-group><article-title>Hypolipidemic and antioxidant activity of enoki mushrooms (Flammulina velutipes)</article-title><source>Biomed. Res. Int.</source><year>2014</year><volume>2014</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1155/2014/352385</pub-id></element-citation></ref><ref id="B86-molecules-26-00251"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alves</surname><given-names>M.J.</given-names></name><name><surname>Ferreira</surname><given-names>I.C.</given-names></name><name><surname>Dias</surname><given-names>J.</given-names></name><name><surname>Teixeira</surname><given-names>V.</given-names></name><name><surname>Martins</surname><given-names>A.</given-names></name><name><surname>Pintado</surname><given-names>M.</given-names></name></person-group><article-title>A review on antifungal activity of mushroom (basidiomycetes) extracts and isolated compounds</article-title><source>Curr. Top. Med. Chem.</source><year>2013</year><volume>13</volume><fpage>2648</fpage><lpage>2659</lpage><pub-id pub-id-type="doi">10.2174/15680266113136660191</pub-id><?supplied-pmid 24083794?><pub-id pub-id-type="pmid">24083794</pub-id></element-citation></ref><ref id="B87-molecules-26-00251"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>I.C.F.R.</given-names></name><name><surname>Vaz</surname><given-names>J.A.</given-names></name><name><surname>Vasconcelos</surname><given-names>M.H.</given-names></name><name><surname>Martins</surname><given-names>A.</given-names></name></person-group><article-title>Compounds from wild mushrooms with antitumor potential</article-title><source>Anti-Cancer Agents Med. Chem.</source><year>2010</year><volume>10</volume><fpage>424</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.2174/1871520611009050424</pub-id></element-citation></ref><ref id="B88-molecules-26-00251"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M.M.</given-names></name><name><surname>Qiao</surname><given-names>Y.</given-names></name><name><surname>Ang</surname><given-names>E.L.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name></person-group><article-title>Using natural products for drug discovery: The impact of the genomics era</article-title><source>Expert Opin. Drug Disc.</source><year>2017</year><volume>12</volume><fpage>475</fpage><lpage>487</lpage><pub-id pub-id-type="doi">10.1080/17460441.2017.1303478</pub-id></element-citation></ref><ref id="B89-molecules-26-00251"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skinnider</surname><given-names>M.A.</given-names></name><name><surname>Dejong</surname><given-names>C.A.</given-names></name><name><surname>Rees</surname><given-names>P.N.</given-names></name><name><surname>Johnstone</surname><given-names>C.W.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Webster</surname><given-names>A.L.</given-names></name><name><surname>Wyatt</surname><given-names>M.A.</given-names></name><name><surname>Magarvey</surname><given-names>N.A.</given-names></name></person-group><article-title>Genomes to natural products: Prediction Informatics for secondary metabolomes (PRISM)</article-title><source>Nucleic Acids Res.</source><year>2015</year><volume>43</volume><fpage>9645</fpage><lpage>9662</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv1012</pub-id><pub-id pub-id-type="pmid">26442528</pub-id></element-citation></ref><ref id="B90-molecules-26-00251"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skellam</surname><given-names>E.</given-names></name></person-group><article-title>Strategies for engineering natural product biosynthesis in fungi</article-title><source>Trends Biotech.</source><year>2019</year><volume>37</volume><fpage>416</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1016/j.tibtech.2018.09.003</pub-id></element-citation></ref><ref id="B91-molecules-26-00251"><label>91.</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>H.</given-names></name><name><surname>Tsang</surname><given-names>A.</given-names></name><name><surname>Diallo</surname><given-names>A.B.</given-names></name></person-group><article-title>Towards accurate identification of biosynthetic gene clusters in fungi. F1000 Research</article-title><source>Proceedings of the ISMB/ECCB</source><conf-loc>Basel, Switzerland</conf-loc><conf-date>21&#x02013;25 July 2019</conf-date></element-citation></ref><ref id="B92-molecules-26-00251"><label>92.</label><element-citation publication-type="web"><article-title>California Fungi: Gymnopus dryophilus&#x02014;MycoWeb</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.mykoweb.com/CAF/species/Gymnopus_dryophilus.html">https://www.mykoweb.com/CAF/species/Gymnopus_dryophilus.html</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-11-18">(accessed on 18 November 2020)</date-in-citation></element-citation></ref><ref id="B93-molecules-26-00251"><label>93.</label><element-citation publication-type="web"><article-title><italic>Marasmius oreades</italic> (Bolton) Fr.&#x02014;Fairy Ring Champignon</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.first-nature.com/fungi/marasmius-oreades.php">https://www.first-nature.com/fungi/marasmius-oreades.php</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-11-18">(accessed on 18 November 2020)</date-in-citation></element-citation></ref><ref id="B94-molecules-26-00251"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehlers</surname><given-names>T.</given-names></name><name><surname>Hobby</surname><given-names>T.</given-names></name></person-group><article-title>The chanterelle mushroom harvest on northern Vancouver Island, British Columbia: Factors relating to successful commercial development</article-title><source>BC J. Ecosyst. Manag.</source><year>2010</year><volume>11</volume><fpage>72</fpage><lpage>83</lpage></element-citation></ref><ref id="B95-molecules-26-00251"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>M.</given-names></name><name><surname>Dewsbury</surname><given-names>D.R.</given-names></name><name><surname>O&#x02019; Donnell</surname><given-names>K.</given-names></name><name><surname>Carter</surname><given-names>A.M.</given-names></name><name><surname>Rehner</surname><given-names>S.A.</given-names></name><name><surname>Moore</surname><given-names>J.D.</given-names></name><name><surname>Moncalvo</surname><given-names>J.-M.</given-names></name><name><surname>Canfield</surname><given-names>S.A.</given-names></name><name><surname>Stephenson</surname><given-names>S.L.</given-names></name><name><surname>Methven</surname><given-names>A.S.</given-names></name><etal/></person-group><article-title>Taxonomic revision of true morels (<italic>Morchella</italic>) in Canada and the United States</article-title><source>Mycologia</source><year>2012</year><volume>104</volume><fpage>1159</fpage><lpage>1177</lpage><pub-id pub-id-type="doi">10.3852/11-375</pub-id><pub-id pub-id-type="pmid">22495449</pub-id></element-citation></ref><ref id="B96-molecules-26-00251"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laperriere</surname><given-names>G.</given-names></name><name><surname>Desgagne-Penix</surname><given-names>I.</given-names></name><name><surname>Germain</surname><given-names>H.</given-names></name></person-group><article-title>DNA distribution and metabolite profile of wild edible lobster mushroom (<italic>Hypomyces lactifluorum/Russula brevipes</italic>)</article-title><source>Genome</source><year>2018</year><volume>61</volume><fpage>329</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1139/gen-2017-0168</pub-id><pub-id pub-id-type="pmid">29514010</pub-id></element-citation></ref><ref id="B97-molecules-26-00251"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antkowiak</surname><given-names>W.Z.</given-names></name><name><surname>Gessner</surname><given-names>W.P.</given-names></name></person-group><article-title>The structure of orellanine and orelline</article-title><source>Tetrahedon Lett.</source><year>1979</year><volume>20</volume><fpage>1931</fpage><lpage>1934</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(01)86882-9</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="molecules-26-00251-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Classification of bioactive compounds isolated from mushrooms.</p></caption><graphic xlink:href="molecules-26-00251-g001"/></fig><fig id="molecules-26-00251-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Structures of small molecules isolated from mushrooms native to North America.</p></caption><graphic xlink:href="molecules-26-00251-g002"/></fig><table-wrap id="molecules-26-00251-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-26-00251-t001_Table 1</object-id><label>Table 1</label><caption><p>Mushrooms Native to North America Studied for Bioactivities.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mushroom Species</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Origin</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Bioactivity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Bioactive Component <sup>1</sup> or Extraction Solvent</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Active Dose <sup>2</sup></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Albatrellus flettii</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">La Crosse, Wisconsin</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial [<xref rid="B21-molecules-26-00251" ref-type="bibr">21</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">Grifolin (<bold>3</bold>)<break/>Neogrifolin (<bold>4</bold>)<break/>Confluentin (<bold>5</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">MIC = 10 &#x003bc;g/mL (<bold>3</bold>), 20 &#x003bc;g/mL (<bold>4</bold>,<bold>5</bold>) on B. cereus. MIC = 0.5 &#x003bc;g/mL (<bold>3</bold>,<bold>4</bold>), 1 &#x003bc;g/mL (<bold>5</bold>) on E. faecalis</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Albatrellus flettii</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Smithers, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative [<xref rid="B22-molecules-26-00251" ref-type="bibr">22</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">Grifolin (<bold>3</bold>)<break/>Neogrifolin (<bold>4</bold>)<break/>Confluentin (<bold>5</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">IC<sub>50</sub> = 27.4 &#x003bc;M (3), 24.3 &#x003bc;M (4), 25.9 &#x003bc;M (5) on HeLa. IC<sub>50</sub> = 35.4 &#x003bc;M (<bold>3</bold>), 34.6 &#x003bc;M (4), 33.5 &#x003bc;M (<bold>5</bold>) on SW480.<break/>IC<sub>50</sub> = 30.7 &#x003bc;M (<bold>3</bold>), 30.1 &#x003bc;M (<bold>4</bold>), 25.8 &#x003bc;M (<bold>5</bold>) on HT29.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Amanita augusta</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">50% methanol (a) and 5% NaOH (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">IC<sub>50</sub> = 0.7 mg/mL (a),<break/>0.55 mg/mL (b)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Amanita augusta</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Immuno-stimulatory [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">Water</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Amanita augusta</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">5% NaOH</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Amanita muscaria</td><td align="center" valign="middle" rowspan="1" colspan="1">Prince George, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a) and 50% methanol (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">IC<sub>50</sub> = 0.2 mg/mL (a) (+++)<break/>IC<sub>50</sub> = 0.6 mg/mL (b) (++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Amanita muscaria</td><td align="center" valign="middle" rowspan="1" colspan="1">Prince George, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Immuno-stimulatory [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">2% ammonium oxalate </td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Astraeus pteridis</td><td align="center" valign="middle" rowspan="1" colspan="1">Linn County, Oregon</td><td align="center" valign="middle" rowspan="1" colspan="1">Antituberculosis [<xref rid="B25-molecules-26-00251" ref-type="bibr">25</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">95% ethanol</td><td align="center" valign="middle" rowspan="1" colspan="1">IC<sub>50</sub> = &#x0003c; 20 &#x003bc;g/mL (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Auricularia fuscosuccinea</td><td align="center" valign="middle" rowspan="1" colspan="1">Oxford, Ohio</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial [<xref rid="B26-molecules-26-00251" ref-type="bibr">26</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">Water</td><td align="center" valign="middle" rowspan="1" colspan="1">Against B. subtilis (+++), P. aeruginosa, S. epidermidis (MIC = 1 mg/mL), P. fluorescens, M. luteus (++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Barssia oregonensis</td><td align="center" valign="middle" rowspan="1" colspan="1">Clackamas, Oregon</td><td align="center" valign="middle" rowspan="1" colspan="1">Antituberculosis [<xref rid="B25-molecules-26-00251" ref-type="bibr">25</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">95% ethanol</td><td align="center" valign="middle" rowspan="1" colspan="1">IC<sub>50</sub> = 20&#x02013;50 &#x003bc;g/mL (++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cantharellus cibarius</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1 mg/mL</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cantharellus cibarius</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Weak immuno-stimulatory [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">Water</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cantharellus cibarius</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol, 50% methanol, water and 5% NaOH</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Chroogomphus tomentosus</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative (a), immuno-stimulatory (b) [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a) and water (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2 mg/mL (a) (++), 1 mg/mL (b) (++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Chroogomphus tomentosus</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a) and 50% methanol (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (a,b) (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Clavulina cinerea</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol</td><td align="center" valign="middle" rowspan="1" colspan="1">(++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Coprinellus sp.</td><td align="center" valign="middle" rowspan="1" colspan="1">Seattle, WA, USA</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative [<xref rid="B27-molecules-26-00251" ref-type="bibr">27</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">Water</td><td align="center" valign="middle" rowspan="1" colspan="1">IC<sub>50</sub> = 40 &#x003bc;g/mL on MDA-MB-231 cells (+++),<break/>120 &#x003bc;g/mL on MCF-7 cells (+), 150 &#x003bc;g/mL on BT-20 cells (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Coprinus comatus</td><td align="center" valign="middle" rowspan="1" colspan="1">Seattle, WA, USA</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative </td><td align="center" valign="middle" rowspan="1" colspan="1">Water (a) [<xref rid="B27-molecules-26-00251" ref-type="bibr">27</xref>],<break/>Protein (b) [<xref rid="B28-molecules-26-00251" ref-type="bibr">28</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">IC<sub>50</sub> = 400 &#x003bc;g/mL on MDA-MB-231 cells (a), 450 &#x003bc;g/mL on MCF-7 cells (a), 10 &#x003bc;M (b)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Cortinarius armillatus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Massachusetts</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative [<xref rid="B19-molecules-26-00251" ref-type="bibr">19</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">Orellanine</td><td align="center" valign="middle" rowspan="1" colspan="1">20 &#x003bc;g/mL clear cell RCC (a), 40 &#x003bc;M (10 mg/L) intraperitoneal injection via PD solution (b)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Echinodontium tinctorium</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Smithers and Terrace, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B18-molecules-26-00251" ref-type="bibr">18</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">Polysaccharide AIPetinc</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Elaphomyces granulatus</td><td align="center" valign="middle" rowspan="1" colspan="1">Oregon and Bonner County, Idaho</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B25-molecules-26-00251" ref-type="bibr">25</xref>,<xref rid="B29-molecules-26-00251" ref-type="bibr">29</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">Syringaldehyde (<bold>1</bold>), Syringic acid (<bold>2</bold>), and 95% ethanol (a) </td><td align="center" valign="middle" rowspan="1" colspan="1">IC<sub>50</sub> = 3.5 &#x003bc;g/mL (<bold>1</bold>) (19.23 &#x003bc;M) (+)<break/>IC<sub>50</sub> = 0.4 &#x003bc;g/mL (<bold>2</bold>) (2.02 &#x003bc;M) (+++)<break/>50 &#x003bc;g/mL (a) (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Elaphomyces granulatus</td><td align="center" valign="middle" rowspan="1" colspan="1">Oregon and Bonner County, Idaho</td><td align="center" valign="middle" rowspan="1" colspan="1">Antioxidant [<xref rid="B29-molecules-26-00251" ref-type="bibr">29</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">Syringic acid (<bold>2</bold>) <break/>and 95% ethanol</td><td align="center" valign="middle" rowspan="1" colspan="1">IC<sub>50</sub> = 0.7 &#x003bc;g/mL (2) (+++)<break/>Extract IC<sub>50</sub> = 41 &#x003bc;g/mL</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Elaphomyces muricatus</td><td align="center" valign="middle" rowspan="1" colspan="1">Benton County, Oregon</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory (a), antioxidant (b), antituberculosis (c) [<xref rid="B25-molecules-26-00251" ref-type="bibr">25</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">95% ethanol (a,c), 70% ethanol (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">50 &#x003bc;g/mL (a) (++), IC<sub>50</sub> &#x02265; 50 &#x003bc;g/mL (a) (+), IC<sub>50</sub> &#x02265; 50 &#x003bc;g/mL (a) (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Flammulina velutipes</td><td align="center" valign="middle" rowspan="1" colspan="1">Seattle, WA, USA</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative [<xref rid="B27-molecules-26-00251" ref-type="bibr">27</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">Water</td><td align="center" valign="middle" rowspan="1" colspan="1">IC<sub>50</sub> = 30 &#x003bc;g/mL on BT-20 cells (+++),<break/>75 &#x003bc;g/mL on MDA-MB-231 cells (++),<break/>150 &#x003bc;g/mL on MCF-7 cells (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Fomes fomentarius</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Prince George, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a) and 50% methanol (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.5 mg/mL (a) (+++), 0.5 mg/mL (b) (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Fomes fomentarius</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Prince George, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Immuno-stimulatory [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">Water (a) and 2% ammonium oxalate (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (a) (+), 1 mg/mL (b) (++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Fomitopsis pinicola</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Oregon, USA</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial [<xref rid="B30-molecules-26-00251" ref-type="bibr">30</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">3-Oxo-24-methyl-5&#x003b1;-lanost-8,25-dien-21-oic acid (<bold>30</bold>), pinicolic acid (<bold>31</bold>), polyporenic acid (<bold>32</bold>), 16&#x003b1;-hydroxy-24-methylene-3-oxo-5&#x003b1;-lanost-8-ene-21-oic acid (<bold>33</bold>), 16&#x003b1;-acetyloxy-24-methylene-3-oxo-5&#x003b1;-lanost-7,9(11)-dien-21-oic acid (<bold>34</bold>), 22E-5&#x003b1;-ergost-7,9(11),22-trien-3&#x003b2;-ol (<bold>35</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">MIC = 32 &#x003bc;g/mL (<bold>30</bold>) (++),<break/>16 &#x003bc;g/mL (<bold>31</bold>) (++), 32 &#x003bc;g/mL (<bold>32</bold>) (++), 32 &#x003bc;g/mL (<bold>33</bold>) (++), 128 &#x003bc;g/mL (<bold>34</bold>) (+), 64 &#x003bc;g/mL (<bold>35</bold>) (++) against B. cereus</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ganoderma applanatum</td><td align="center" valign="middle" rowspan="1" colspan="1">Terrace, BC and Oxford, Ohio</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a) and water (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.5 mg/mL (a) (++), 1 mg/mL (b) (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ganoderma applanatum</td><td align="center" valign="middle" rowspan="1" colspan="1">Terrace, BC and Oxford, Ohio</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a) and 50% methanol (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (a) (+++), 1 mg/mL (b) (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ganoderma applanatum</td><td align="center" valign="middle" rowspan="1" colspan="1">Terrace, BC and Oxford, Ohio</td><td align="center" valign="middle" rowspan="1" colspan="1">Immuno-stimulatory [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">Water(a), 5% NaOH (b), and 2% ammonium oxalate (c)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (a) (+++), 1 mg/mL (b) (+), 1 mg/mL (c) (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ganoderma applanatum</td><td align="center" valign="middle" rowspan="1" colspan="1">Terrace, BC and Oxford, Ohio</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial [<xref rid="B26-molecules-26-00251" ref-type="bibr">26</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">Water </td><td align="center" valign="middle" rowspan="1" colspan="1">Against P. aeruginosa, P. fluorescens, B. subtilis, S. epidermidis, (MIC = 100 mg/mL (isolate 1), 10 mg/mL (isolate 2), and M. luteus (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ganoderma lucidum</td><td align="center" valign="middle" rowspan="1" colspan="1">Oxford, Ohio</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial [<xref rid="B26-molecules-26-00251" ref-type="bibr">26</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">Water </td><td align="center" valign="middle" rowspan="1" colspan="1">MIC = 0.1 mg/mL (+++) against S. epidermidis</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ganoderma tsugae</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative (a), immuno-stimulatory (b) [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a) and water (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">(a) (++),1 mg/mL (b) (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ganoderma tsugae</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a) and 5% NaOH (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (a) (+++), 1 mg/mL (b) (++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Gautieria monticola</td><td align="center" valign="middle" rowspan="1" colspan="1">Benton County, Oregon</td><td align="center" valign="middle" rowspan="1" colspan="1">Antioxidant [<xref rid="B25-molecules-26-00251" ref-type="bibr">25</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">70% ethanol</td><td align="center" valign="middle" rowspan="1" colspan="1">IC<sub>50</sub> = &#x0003e; 50 &#x003bc;g/mL (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Geopora clausa</td><td align="center" valign="middle" rowspan="1" colspan="1">Inyo Country, California</td><td align="center" valign="middle" rowspan="1" colspan="1">Antioxidant (a), anti-proliferative [<xref rid="B25-molecules-26-00251" ref-type="bibr">25</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">70% ethanol</td><td align="center" valign="middle" rowspan="1" colspan="1">IC<sub>50</sub> = 20&#x02013;50 &#x003bc;g/mL (a) (++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Guepina helvelloides</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative (a), immuno-stimulatory (b) [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1"> 80% ethanol (a) and water (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">(a) (++),1 mg/mL (b) (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Guepina helvelloides</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a), 50% methanol (b), and 5% NaOH (c)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Gymnopus dryophilus</td><td align="center" valign="middle" rowspan="1" colspan="1">Quebec</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B31-molecules-26-00251" ref-type="bibr">31</xref>,<xref rid="B32-molecules-26-00251" ref-type="bibr">32</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">CDP polysaccharide</td><td align="center" valign="middle" rowspan="1" colspan="1">400 and 800 &#x003bc;g/mL</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Gyromitra esculenta</td><td align="center" valign="middle" rowspan="1" colspan="1">Prince George, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol, 50% methanol</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Gyromitra esculenta</td><td align="center" valign="middle" rowspan="1" colspan="1">Prince George, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Immuno-stimulatory [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol, 50% methanol, water</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Haploporus odorus</td><td align="center" valign="middle" rowspan="1" colspan="1">Study conducted in Calgary, Canada</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial [<xref rid="B33-molecules-26-00251" ref-type="bibr">33</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">Extracts</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Hericium corralloides</td><td align="center" valign="middle" rowspan="1" colspan="1">Prince George, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Immuno-stimulatory [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">50% methanol (a), water (b), 5% NaOH (c)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (a) (++), 1 mg/mL (b) (++), 1 mg/mL (c) (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Hericium corralloides</td><td align="center" valign="middle" rowspan="1" colspan="1">Prince George, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Hericium</italic> sp.</td><td align="center" valign="middle" rowspan="1" colspan="1">Minnesota</td><td align="center" valign="middle" rowspan="1" colspan="1">Antifungal [<xref rid="B17-molecules-26-00251" ref-type="bibr">17</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1"> 2-chloro-1,3-dimethoxy-5-methyl benzene (10)</td><td align="center" valign="middle" rowspan="1" colspan="1">MIC = 31.3&#x02013;62.5 &#x003bc;g/mL against <italic>C. albicans</italic> and <italic>C. neoformans</italic></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Hericium</italic> sp.</td><td align="center" valign="middle" rowspan="1" colspan="1">Minnesota</td><td align="center" valign="middle" rowspan="1" colspan="1">Antifungal (a), antibacterial (b) [<xref rid="B17-molecules-26-00251" ref-type="bibr">17</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">Ethyl acetate, acetone, methanol</td><td align="center" valign="middle" rowspan="1" colspan="1">MIC = 250 &#x003bc;g/mL against <italic>C. albicans</italic> and <italic>C. neoformans</italic> (a), MIC &#x0003e; 500 &#x003bc;g/mL) against <italic>S. aureus</italic> (b)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Hydnellum sp.</td><td align="center" valign="middle" rowspan="1" colspan="1">Prince George, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative (a), immuno-stimulatory (b) [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol, 50% methanol, water</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (a) (++), 1 mg/mL (b) (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Hydnum repandum</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative (a), anti-inflammatory (b &#x00026; c) [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a) (b) and 50% methanol (c)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.6 mg/mL (a) (++), 1 mg/mL (b) (+++), 1 mg/mL (c) (++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Hygrophoropsis aurantiaca</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative, [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">50% methanol, water and 5% NaOH</td><td align="center" valign="middle" rowspan="1" colspan="1">(+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Hygrophoropsis aurantiaca</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol, 50% methanol, and water</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Hymenogaster subalpinus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Benton County, Oregon</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory (a), antituberculosis (b) [<xref rid="B25-molecules-26-00251" ref-type="bibr">25</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">95% ethanol</td><td align="center" valign="middle" rowspan="1" colspan="1">50 &#x003bc;g/mL (a) (++), IC50 = &#x0003c; 20 &#x003bc;g/mL (b) (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Hymenopellis furfuracea</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Oxford, Ohio</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial [<xref rid="B26-molecules-26-00251" ref-type="bibr">26</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">Water</td><td align="center" valign="middle" rowspan="1" colspan="1">Against P. fluorescens, M. luteus (++), B. subtilis, S. episdermidis (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Hypholoma fasciculare</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a) and 50% methanol (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2 mg/mL (a) (++), 0.1 mg/mL (b) (++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Hypholoma fasciculare</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol, 50% methanol, and water</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Inocybe sp.</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative, [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol</td><td align="center" valign="middle" rowspan="1" colspan="1">(++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Inocybe sp.</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Immuno-stimulatory [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">50% methanol and water</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Inocybe sp.</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a) and 5% NaOH (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (a) (+++), 1 mg/mL (b) (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Inonotus obliquus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Manitoba &#x00026; Prince George, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B34-molecules-26-00251" ref-type="bibr">34</xref>,<xref rid="B35-molecules-26-00251" ref-type="bibr">35</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">50% methanol</td><td align="center" valign="middle" rowspan="1" colspan="1">0.25 &#x003bc;g/&#x003bc;L (a), 1 &#x003bc;g/&#x003bc;L in vivo (b)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Jahnoporus hirtus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">USA</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial [<xref rid="B21-molecules-26-00251" ref-type="bibr">21</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">3,11-Dioxolanosta-8,24(<italic>Z</italic>)-diene-26-oic acid (6)</td><td align="center" valign="middle" rowspan="1" colspan="1">40 &#x003bc;g/mL (B. cereus), 32 &#x003bc;g/mL (E. faecalis)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Laetiporus conifericola</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative (a), immuno-stimulatory (b), anti-inflammatory (c) [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a,c) and water (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">(++), 1 mg/mL (b) (++), 1 mg/mL (c) (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Laetiporus sulphureus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Oxford, Ohio</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial [<xref rid="B26-molecules-26-00251" ref-type="bibr">26</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">Water </td><td align="center" valign="middle" rowspan="1" colspan="1">MIC = 0.1 mg/mL (+++) against S. epidermidis</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Lentinellus subaustralis</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Oxford, Ohio</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial [<xref rid="B26-molecules-26-00251" ref-type="bibr">26</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">Water </td><td align="center" valign="middle" rowspan="1" colspan="1">Against P. aeruginosa, and B. subtilis (+), P. fluorescens, S. epidermidis (MIC = 10 mg/mL), and M. luteus</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Lentinus edodes</td><td align="center" valign="middle" rowspan="1" colspan="1">Quebec</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B31-molecules-26-00251" ref-type="bibr">31</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">CDP-like polysaccharide</td><td align="center" valign="middle" rowspan="1" colspan="1">50 &#x003bc;g/mL (++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Leucogaster rubescens</td><td align="center" valign="middle" rowspan="1" colspan="1">Pend Oreille County, Oregon</td><td align="center" valign="middle" rowspan="1" colspan="1">Antioxidant [<xref rid="B25-molecules-26-00251" ref-type="bibr">25</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">95% ethanol</td><td align="center" valign="middle" rowspan="1" colspan="1">IC<sub>50</sub> = 20&#x02013;50 &#x003bc;g/mL (++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Leucocybe connata</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Prince George, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative (a), anti-inflammatory (b) [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">5% NaOH (a) and 80% ethanol (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (a) (++), 1 mg/mL (b) (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Leucocybe connata</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Prince George, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Immuno-stimulatory [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">Water, 5% NaOH</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Leucopaxillus albissimus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">USA</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial [<xref rid="B36-molecules-26-00251" ref-type="bibr">36</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2-Aminoquinoline</td><td align="center" valign="middle" rowspan="1" colspan="1">MIC = 8&#x02013;65 &#x003bc;g/mL against multidrug resistant clinical isolates (++), 128 &#x003bc;g/mL against A. baumannio (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Marasmius oreades</td><td align="center" valign="middle" rowspan="1" colspan="1">Quebec</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B31-molecules-26-00251" ref-type="bibr">31</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">CDP-like polysaccharide</td><td align="center" valign="middle" rowspan="1" colspan="1">50 &#x003bc;g/mL (++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Melanogaster tuberiformis</td><td align="center" valign="middle" rowspan="1" colspan="1">Lane County, Oregon</td><td align="center" valign="middle" rowspan="1" colspan="1">Antituberculosis (a), anti-inflammatory (b), antioxidant (c) [<xref rid="B25-molecules-26-00251" ref-type="bibr">25</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">95% ethanol</td><td align="center" valign="middle" rowspan="1" colspan="1">IC<sub>50</sub> = &#x0003c; 20 &#x003bc;g/mL (a) (+++), 50 &#x003bc;g/mL (b) (++), IC50 = &#x0003e; 50 &#x003bc;g/mL (c) (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Paxillus involutus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Prince George, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative [<xref rid="B37-molecules-26-00251" ref-type="bibr">37</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">GIPinv Polysaccharide</td><td align="center" valign="middle" rowspan="1" colspan="1">IC<sub>50</sub> = 0.05 mg/mL (+++) on HeLa,0.04 mg/mL (++) on MCF-7</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Phellinopsis conchata</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Oxford, Ohio</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial [<xref rid="B26-molecules-26-00251" ref-type="bibr">26</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">Water</td><td align="center" valign="middle" rowspan="1" colspan="1">MIC = 1 mg/mL against S. epidermidis (++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Phellinus conchatus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Oxford, Ohio</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial [<xref rid="B26-molecules-26-00251" ref-type="bibr">26</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">Water</td><td align="center" valign="middle" rowspan="1" colspan="1">MIC = 100 mg/mL against S. epidermidis (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Phellinus igniarius</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Terrace, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a), water (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2 mg/mL (a) (+++), 1 mg/mL (b) (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Phellinus igniarius</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Terrace, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Phellinus nigricans</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Terrace, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a), water (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (a) (+), 1 mg/mL (b) (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Phellinus nigricans</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Terrace, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Immuno-stimulatory (a,b), anti-inflammatory (c) [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">Water (a), 5% NaOH (b), and 50% methanol (c)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (a) (+), 1 mg/mL (b) (+++), 1 mg/mL (c) (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Phellodon atratus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative, immuno-stimulatory (b &#x00026; c) [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a), 50% methanol (b) and water (c)</td><td align="center" valign="middle" rowspan="1" colspan="1">(a) (+), 1 mg/mL (b,c) (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Phellodon atratus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a) and 5% NaOH (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (a) (+++), 1 mg/mL (b) (++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Pholiota terrestris</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Oxford, Ohio</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial [<xref rid="B26-molecules-26-00251" ref-type="bibr">26</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">Water</td><td align="center" valign="middle" rowspan="1" colspan="1">Against S. epidermidis, P. fluorescens, and M. luteus (++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Piptoporus betulinus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Prince George, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a) and water (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1 mg/mL (a) (+++), 0.2 mg/mL (b) (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Piptoporus betulinus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Prince George, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a), 50% methanol (b) and water (c)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (a&#x02013;c)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Pleurotus djamor</td><td align="center" valign="middle" rowspan="1" colspan="1">Study from Mexico</td><td align="center" valign="middle" rowspan="1" colspan="1">Anthelmintic activity [<xref rid="B38-molecules-26-00251" ref-type="bibr">38</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">Hydro-alcoholic extracts, Pentadecanoic, hexadecanoic, octadecadienoic, octadecanoic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">40 mg/mL</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Pleurotus levis</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Mexico</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial (a) (+++), antioxidant (b) (+++) [<xref rid="B39-molecules-26-00251" ref-type="bibr">39</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">Water and alcohol</td><td align="center" valign="middle" rowspan="1" colspan="1">MIC = 3.33 &#x003bc;g/mL against B. subtilis, 13.32 &#x003bc;g/mL against S. agalactiae (a), 26.64 &#x003bc;g/mL against S. aureus, EC-50 = 0.52 &#x003bc;g/mL (b) (DPPH assay)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Pleurotus ostreatus</td><td align="center" valign="middle" rowspan="1" colspan="1">USA &#x00026; Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative (a), anti-inflammatory (b) [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol, 50% methanol</td><td align="center" valign="middle" rowspan="1" colspan="1">(a) (++), 1 mg/mL (b) (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Pleurotus ostreatus</td><td align="center" valign="middle" rowspan="1" colspan="1">USA &#x00026; Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Immuno-stimulatory [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">Water</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Pleurotus ostreatus</td><td align="center" valign="middle" rowspan="1" colspan="1">USA &#x00026; Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Antioxidant (a), Antimicrobial (b) [<xref rid="B39-molecules-26-00251" ref-type="bibr">39</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">Water and alcohol</td><td align="center" valign="middle" rowspan="1" colspan="1">EC<sub>50</sub> = 1.05 &#x003bc;g/mL (a) (++) (DPPH assay), MIC = 7.83 &#x003bc;g/mL (b) (+) against S. agalactiae</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Pleurotus tuber-regium</td><td align="center" valign="middle" rowspan="1" colspan="1">Olympia, WA</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative (a) [<xref rid="B40-molecules-26-00251" ref-type="bibr">40</xref>], antimicrobial (b) [<xref rid="B39-molecules-26-00251" ref-type="bibr">39</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">Polysaccharide (a), and water and alcohol (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">MIC = 6.03 &#x003bc;g/mL (b) (++) against S. agalactiae</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Polyporus badius</td><td align="center" valign="middle" rowspan="1" colspan="1">Oxford, Ohio</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial [<xref rid="B26-molecules-26-00251" ref-type="bibr">26</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">Water</td><td align="center" valign="middle" rowspan="1" colspan="1">(+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Polyporus squamosus</td><td align="center" valign="middle" rowspan="1" colspan="1">Oxford, Ohio</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial [<xref rid="B26-molecules-26-00251" ref-type="bibr">26</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">Water</td><td align="center" valign="middle" rowspan="1" colspan="1">(MIC = 10 mg/mL (isolate 1&#x00026;2), 100 mg/mL (isolate 3), and M. luteus</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Pseudoinonotus dryadeus</td><td align="center" valign="middle" rowspan="1" colspan="1">Oxford, Ohio</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial [<xref rid="B26-molecules-26-00251" ref-type="bibr">26</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">100% methanol</td><td align="center" valign="middle" rowspan="1" colspan="1">(++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Pyrofomes demidoffi</td><td align="center" valign="middle" rowspan="1" colspan="1">Oxford, Ohio</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial [<xref rid="B26-molecules-26-00251" ref-type="bibr">26</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">Water</td><td align="center" valign="middle" rowspan="1" colspan="1">MIC = 1 mg/mL against S. epidermidis (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ramaria cystidiophora</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a), 50% methanol (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1 mg/mL (a) (+++), 0.8 mg/mL (b) (++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ramaria cystidiophora</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a), 50% methanol (b), water (c) and 5% NaOH (d)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (a-d) (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ramaria cystidiophora</td><td align="center" valign="middle" rowspan="1" colspan="1">Vancouver, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial [<xref rid="B26-molecules-26-00251" ref-type="bibr">26</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">Ramariolide A (22)</td><td align="center" valign="middle" rowspan="1" colspan="1">MIC = 8 &#x003bc;g/mL against M. smegmatis, 64&#x02212;128 &#x003bc;g/mL against M. tuberculosis</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rhizopogon couchii</td><td align="center" valign="middle" rowspan="1" colspan="1">Lebanon State Forest, New Jersey</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory, antioxidant, antituberculosis [<xref rid="B25-molecules-26-00251" ref-type="bibr">25</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">95% ethanol</td><td align="center" valign="middle" rowspan="1" colspan="1">50 g/mL (a) (++), IC50 = 20&#x02013;50 &#x003bc;g/mL (b) (++), IC50 = 20&#x02013;50 &#x003bc;g/mL (b) (++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rhizopogon nigrescens</td><td align="center" valign="middle" rowspan="1" colspan="1">Lebanon State Forest, New Jersey</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory (a), antioxidant (b) [<xref rid="B25-molecules-26-00251" ref-type="bibr">25</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">95% ethanol</td><td align="center" valign="middle" rowspan="1" colspan="1">50 g/mL (a) (+++), IC50 = &#x0003e; 50 &#x003bc;g/mL (b) (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rhizopogon pedicellus</td><td align="center" valign="middle" rowspan="1" colspan="1">Pend Oreille County, Oregon</td><td align="center" valign="middle" rowspan="1" colspan="1">Antioxidant (a), antituberculosis (b) [<xref rid="B25-molecules-26-00251" ref-type="bibr">25</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">95% ethanol (a),70% ethanol (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">IC<sub>50</sub> = 20&#x02013;50 &#x003bc;g/mL (a) (++), IC<sub>50</sub> &#x02265; 50 &#x003bc;g/mL (b) (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rhizopogon subareolatus</td><td align="center" valign="middle" rowspan="1" colspan="1">Lewis County, Washington</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimalarial [<xref rid="B25-molecules-26-00251" ref-type="bibr">25</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">95% ethanol (+)</td><td align="center" valign="middle" rowspan="1" colspan="1">15.9 &#x003bc;g/mL (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rhizopogon subaustralis</td><td align="center" valign="middle" rowspan="1" colspan="1">Lebanon State Forest, New Jersey</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory (a), antioxidant (b) [<xref rid="B25-molecules-26-00251" ref-type="bibr">25</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">95% ethanol</td><td align="center" valign="middle" rowspan="1" colspan="1">IC<sub>50</sub> &#x02265; 50 &#x003bc;g/mL (a) (+), 50 &#x003bc;g/mL (b) (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rhizopogon subgelatinosus</td><td align="center" valign="middle" rowspan="1" colspan="1">Jackson County, Oregon</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory (a), anti-proliferative [<xref rid="B25-molecules-26-00251" ref-type="bibr">25</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">95% ethanol</td><td align="center" valign="middle" rowspan="1" colspan="1">50 &#x003bc;g/mL (a)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Russula paludosa</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a), 50% methanol (b), water (c), and 5% NaOH (d)</td><td align="center" valign="middle" rowspan="1" colspan="1">(a&#x02013;d) (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Russula paludosa</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a), 50% methanol (b), water (c)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (a&#x02013;c) (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Scleroderma laeve</td><td align="center" valign="middle" rowspan="1" colspan="1">Lebanon State Forest, New Jersey</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory (a), antioxidant(b), antituberculosis (c) [<xref rid="B25-molecules-26-00251" ref-type="bibr">25</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">95% ethanol (+++)</td><td align="center" valign="middle" rowspan="1" colspan="1">50 &#x003bc;g/mL (a), IC50 = &#x0003c; 20 &#x003bc;g/mL (b), IC50 = &#x0003c; 20 &#x003bc;g/mL (c)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Stereum hirsutum</td><td align="center" valign="middle" rowspan="1" colspan="1">Oxford, Ohio</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial [<xref rid="B26-molecules-26-00251" ref-type="bibr">26</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">Water</td><td align="center" valign="middle" rowspan="1" colspan="1">Against B. subtilis, S. epidermidis, and P. fluorescens (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Trametes versicolor</td><td align="center" valign="middle" rowspan="1" colspan="1">Oxford, Ohio</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial [<xref rid="B26-molecules-26-00251" ref-type="bibr">26</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">Water</td><td align="center" valign="middle" rowspan="1" colspan="1">MIC = 10 mg/mL against S. epidermidis (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Trichaptum abietinum</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Prince George, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a) and water (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2 mg/mL (a) (++), 0.2 mg/mL (b) (+)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Trichaptum abietinum</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Prince George, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Immuno-stimulatory (a), anti-inflammatory (b) [<xref rid="B24-molecules-26-00251" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">50% methanol (a) and 5% NaOH (b) </td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (a) (+++), 1 mg/mL (b)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Tricholomopsis rutilans</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol</td><td align="center" valign="middle" rowspan="1" colspan="1">(++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Tricholomopsis rutilans</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a), 50% methanol (b) and water (c)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (a&#x02013;c) (+++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Tyromyces chioneus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-proliferative (a), immuno-stimulatory (b) [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a) and water (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">(a) (+), 1 mg/mL (b) (++)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Tyromyces chioneus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Haida Gwaii, BC</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory [<xref rid="B23-molecules-26-00251" ref-type="bibr">23</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">80% ethanol (a) and m50% ethanol (b)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg/mL (a) (+++), 1 mg/mL (b) (++)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Urnula craterium</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">La Crosse, Wisconsin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antimicrobial [<xref rid="B41-molecules-26-00251" ref-type="bibr">41</xref>] </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Urnucratin A (27) <break/>Urnucratin B (28) (++)<break/>Urnucratin C (29) (+++)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(27) MIC = 2 &#x003bc;g/mL (+) (methicillin-resistant S aureus), 1 &#x003bc;g/mL (vancomycin-resistant E. faecium), 0.5 &#x003bc;g/mL (S. pyogenes)</td></tr></tbody></table><table-wrap-foot><fn><p>+++ refers to strong activity, ++ moderate activity, + weak activity. <sup>1</sup> Refer to Table 2 for more information of bioactive small molecules and polysaccharides. <sup>2</sup> All studies were conducted in vitro, except where indicated. (a), (b), (c) and (d) in Column 4 (Bioactive Component or Extraction Solvent) are referred to in Column 5 (Active Dose).</p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-26-00251-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-26-00251-t002_Table 2</object-id><label>Table 2</label><caption><p>Bioactive Molecules from Mushrooms Native to North America.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Types</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Bioactive Compound</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mushrooms</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Small molecules</td><td align="center" valign="middle" rowspan="1" colspan="1">Syringaldehyde (1)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B29-molecules-26-00251" ref-type="bibr">29</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>E. granulatus</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Syringic acid (2)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B29-molecules-26-00251" ref-type="bibr">29</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>E. granulatus</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Grifolin (3)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B21-molecules-26-00251" ref-type="bibr">21</xref>,<xref rid="B22-molecules-26-00251" ref-type="bibr">22</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>A. flettii</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Neogrifolin (4)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B21-molecules-26-00251" ref-type="bibr">21</xref>,<xref rid="B22-molecules-26-00251" ref-type="bibr">22</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>A. flettii</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Confluentin (5)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B21-molecules-26-00251" ref-type="bibr">21</xref>,<xref rid="B22-molecules-26-00251" ref-type="bibr">22</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>A. flettii</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">3,11-Dioxolanosta-8,24(<italic>Z</italic>)-diene-26-oic acid <sup>1</sup> (6) </td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B21-molecules-26-00251" ref-type="bibr">21</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>J. hirtus</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Erinacerin V <sup>1</sup> (7)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B17-molecules-26-00251" ref-type="bibr">17</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Hericium</italic> sp.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">4-Hydroxy-2,2-dimethylchromane-6-carbaldehyde <sup>1</sup> (8)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B17-molecules-26-00251" ref-type="bibr">17</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Hericium</italic> sp.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">4-Chloro-3,5-dimethoxybenzaldehyde (9)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B17-molecules-26-00251" ref-type="bibr">17</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Hericium</italic> sp.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">2-Chloro-1,3-dimethoxy-5-methyl benzene (10)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B17-molecules-26-00251" ref-type="bibr">17</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Hericium</italic> sp.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">4-Chloro-3,5-dimethoxyphenylmethanol (11)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B17-molecules-26-00251" ref-type="bibr">17</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Hericium</italic> sp.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">3,6-Bis(hydroxyl methyl)-2-methyl-4<italic>H</italic>-pyran-4-one (12)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B17-molecules-26-00251" ref-type="bibr">17</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Hericium</italic> sp.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">4-Chloro-3,5-dimethoxybenzoic acid (13)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B17-molecules-26-00251" ref-type="bibr">17</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Hericium</italic> sp.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">5-Hydroxy-6-(1-hydroxyethyl)isobenzofuran-1(3<italic>H</italic>)-one (14)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Hericium</italic> sp.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Erinacine (15)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B17-molecules-26-00251" ref-type="bibr">17</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Hericium</italic> sp.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Pentadecanoic acid (16), Hexadecanoic acid (17), Octadecadienoic acid (18), Octadecanoic acid (19) </td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B38-molecules-26-00251" ref-type="bibr">38</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>P. djamar</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Orellanine (3,3&#x02032;,4,4&#x02032;-tetrahydroxy-2,2&#x02032;-bipyridine-1,1&#x02032;-dioxide) (20)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B19-molecules-26-00251" ref-type="bibr">19</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>C. armillatus</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ramariolide A <sup>1</sup> (21)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B50-molecules-26-00251" ref-type="bibr">50</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>R. cystidiophora</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ramariolide B <sup>1</sup> (22)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B50-molecules-26-00251" ref-type="bibr">50</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>R. cystidiophora</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ramariolide C <sup>1</sup> (23)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B50-molecules-26-00251" ref-type="bibr">50</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>R. cystidiophora</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ramariolide D <sup>1</sup> (24)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B50-molecules-26-00251" ref-type="bibr">50</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>R. cystidiophora</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">2-Aminoquinoline (25)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B36-molecules-26-00251" ref-type="bibr">36</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>L. albissimus</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Urnucratin A <sup>1</sup> (26)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B41-molecules-26-00251" ref-type="bibr">41</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>U. craterium</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Urnucratin B <sup>1</sup> (27)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B41-molecules-26-00251" ref-type="bibr">41</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>U. craterium</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Urnucratin C <sup>1</sup> (28)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B41-molecules-26-00251" ref-type="bibr">41</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>U. craterium</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">3-Oxo-24-methyl-5&#x003b1;-lanost-8,25-dien-21-oic acid <sup>1</sup> (29)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B30-molecules-26-00251" ref-type="bibr">30</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>F. pinicola</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Pinicolic acid (30)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B30-molecules-26-00251" ref-type="bibr">30</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>F. pinicola</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Polyporenic acid (31)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B30-molecules-26-00251" ref-type="bibr">30</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>F. pinicola</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">16&#x003b1;-Hydroxy-24-methylene-3-oxo-5&#x003b1;-lanost-8-ene-21-oic acid (32)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B30-molecules-26-00251" ref-type="bibr">30</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>F. pinicola</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">16&#x003b1;-Acetyloxy-24-methylene-3-oxo-5&#x003b1;-lanost-7,9(11)-dien-21-oic acid (33)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B30-molecules-26-00251" ref-type="bibr">30</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>F. pinicola</italic>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22E-5&#x003b1;-Ergost-7,9(11),22-trien-3&#x003b2;-ol (34)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B30-molecules-26-00251" ref-type="bibr">30</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>F. pinicola</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Large molecules</td><td align="center" valign="middle" rowspan="1" colspan="1">GIPinv <sup>1</sup>
</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B37-molecules-26-00251" ref-type="bibr">37</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>P. involutus</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">CDP <sup>1</sup>
</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B31-molecules-26-00251" ref-type="bibr">31</xref>,<xref rid="B32-molecules-26-00251" ref-type="bibr">32</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>G. dryophilus</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">AlPetinc <sup>1</sup>
</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-molecules-26-00251" ref-type="bibr">18</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>E. tinctorium</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">CDP-like polysaccharide <sup>1</sup>
</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B31-molecules-26-00251" ref-type="bibr">31</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>L. edodes</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">CDP-like polysaccharide <sup>1</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B31-molecules-26-00251" ref-type="bibr">31</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>M. oreades</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">EPS <sup>1</sup>
</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B52-molecules-26-00251" ref-type="bibr">52</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>P. tuber-regium</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Y3 <sup>1</sup>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B28-molecules-26-00251" ref-type="bibr">28</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>C. comatus</italic>
</td></tr></tbody></table><table-wrap-foot><fn><p><sup>1</sup> New compounds.</p></fn></table-wrap-foot></table-wrap></floats-group></article>